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ABSTRACT 
COMPARISON OF HEMODYNAMIC EFFECTS OF LIGNOCAINE 2% WITH 
ADRENALINE IN TWO DIFFERENT CONCENTRATIONS OF 1:80,000 AND 
1:2,00,000 
Aims & Objectives: 
  The present study was designed to compare the hemodynamic parameters 
during administration of local anesthetics agent lignocaine 2%  without adrenaline 
and with adrenaline in different concentrations such as 1:80,000 and 1:2, 00,000 in 
minor oral surgical procedures with regard to systolic blood pressure, diastolic blood 
pressure, heart rate and oxygen saturation 
Materials and Methods 
Thirty ASA grade I patients were selected  who were to undergo multiple 
minor oral surgical procedures. All patients received 1.8 ml of local anesthetic 
solutions during each appointment. All patients were categorized into groups based on 
the choice of local anesthetic agent used with there respective concentration of 
adrenaline. The total  no. of groups being three, group I included patients who 
received plain Lignocaine 2%, group II received Lignocaine 2% with adrenaline 
1:80,000 and group III received Lignocaine 2% with adrenaline 1:2, 00,000. Under 
each group, the following parameters such as oxygen saturation, heart rate, systolic 
and diastolic blood pressure were recorded immediately after administration and at 
timely intervals of 5 min, 10 min, 15 min, 20 min and 30 min. 
 
IX 
 
Results: 
It was noticed that oxygen saturation did not show any variations while using 
lignocaine 2% or lignocaine 2% with adrenaline 1:80,000 or lignocaine 2% with 
adrenaline 1: 2,00,000. Those patients who received plain  lignocaine 2% showed 
only minor variations in HR which was not significant while those patients who 
received lignocaine 2%  with adrenaline 1:80,000 and lignocaine 2% with adrenaline 
1:2,00,000 showed an increase in heart rate after administration of local anesthetic. 
Patients receiving local anesthetic with adrenaline in concentrations of 1:80,000 and 
1:2,00,000 showed a bimodal change in systolic blood pressure. An initial decrease in 
systolic blood pressure was noted immediately after administration and then increases 
at 10 min following administration. Again after 10 min period, systolic pressure  
decreased gradually till 30 min. Diastolic blood pressure did not show any variations 
in those patients who received plain lignocaine 2% but was noted to be decreasing in 
patients receiving local anesthesia with adrenaline in concentrations of 1:80,000 and 
1:2,00,000. 
Conclusion: 
To conclude, even though use of lignocaine with adrenaline is associated with 
changes in blood pressure and heart rate, clinically they are less significant and such 
changes did not produce any marked systemic untoward outcome at any of the studied 
adrenaline concentrations of 1:80,000 or 1:2,00,000. 
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Vasoconstrictors are those drugs that constrict blood vessels and thereby 
controlling tissue perfusion.  Most local anaesthetics, except cocaine, are vasodilators. 
Vasoconstrictors are added to local anaesthetic agents to counter their vasodialatory 
effects.  
Vasoconstrictors used commonly in conjunction with local anaesthetics are 
chemically similar to sympathetic nervous system mediators – epinephrine and 
norepinephrine. So their actions resemble adrenergic nerve stimulation. These drugs 
being classified as sympathomimetic or adrenergic drugs have several actions besides 
vasoconstriction. 
The systemic actions of the sympathomimetic amines can be classified into 
five broad types. (1) A cardiac excitatory action resulting in an increase in heart rate, 
force of contraction and stroke volume. (2) A central nervous system excitation 
resulting from the vasoconstrictor agents. (3) Metabolic actions, such as increase in 
the rate of glycogenolysis in the liver. (4) Peripheral excitatory action on smooth 
muscles, including those in blood vessels supplying mucous membrane and skin, 
providing vasoconstrictor effect. (5)The sympathomimetic effect may cause a 
peripheral inhibitory action on certain other types of smooth muscle, such as those in 
the bronchial tree and in the gut wall1. 
The clinical efficiency of a local anaesthetic agent is dependent upon the 
action of the vasoconstrictors. Vasoconstrictors added to local anaesthetic solution 
provide several advantages to the anaesthetic. First, the addition of vasoconstrictor 
increases the duration and depth of anaesthesia and pain control. Second, it can 
decrease the systemic toxicity of local anaesthetics by retarding their absorption into 
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the systemic circulation. Third, the vasoconstrictor provides haemostasis at the 
surgical site and reducing blood loss. Finally, the addition of vasoconstrictor can 
enhance the quality of the neural blockade.2 
Epinephrine is the most commonly employed vasoconstrictor in dentistry. As 
with the other useful vasoconstrictors, epinephrine produces its effects by stimulating 
the alpha adrenergic receptors located in the walls of the arteriole. Epinephrine is also 
a beta adrenergic stimulator and may cause vasodilatation of arterioles in skeletal 
muscle due to the predominance of beta receptors in this tissue. Epinephrine's beta 
adrenergic responses, even at low systemic levels, include skeletal muscle 
vasodilatation with increased heart rate. The beta adrenergic effects predominate over 
the alpha because of the greater sensitivity of beta adrenergic receptors to 
epinephrine. 
The technique of diluting vasoconstrictors in local anaesthetics dates back to 
1897 when Abel discovered adrenaline. Vasoconstrictors commonly used in dental 
surgery are of various dilutions of 1: 80,000, 1: 1, 00,000 and 1: 2, 00,000 having 
0.0125 mg/ml, 0.01 mg/ml and 0.005 mg/ml of epinephrine respectively. 
During local anaesthetic administration, epinephrine is absorbed from the 
injection site just as the local anaesthetic which can influence the heart and blood 
vessels. Lignocaine with adrenaline 1: 2, 00,000 dilution on administration can double 
the plasma epinephrine concentration3.There has long been debate regarding the 
safety of using epinephrine as a vasoconstrictor with local anaesthetics. Current 
evidences in contrast to previous studies demonstrates that intra oral injection of local 
anaesthetics can elevate the plasma epinephrine concentration equivalent to that 
achieved during moderate to heavy exercise4. This is associated with moderate 
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increase in blood pressure and heart rate. Intra vascular administration of epinephrine 
0.015mg can cause an elevation of heart rate of 25 – 70 per minute and systolic blood 
pressure of 20 -70 mm Hg. 
Inadvertent intravascular administration, injections of increased volumes or 
concentrations, or injection into inflamed tissue may enhance the systemic uptake of 
vasoconstrictor and local anaesthetic and produce toxic manifestations. The signs and 
symptoms of vasoconstrictor over dosage include tachycardia, hypertension, tremors, 
headache, palpitations and, rarely ventricular fibrillation by direct effect on the 
myocardium. 
The effect of local anaesthetics with adrenaline in terms of potency and its 
action is well established and documented5, 6. However hemodynamic parameters with 
respect to systemic response need further investigations and understanding. Changes 
such as variable blood pressure, peripheral pulse and heart rate during administration 
and its effect till the cessation of procedure lack clarity. With respect to local 
anaesthesia with different concentrations on adrenaline as well as without adrenaline 
producing such changes require further evaluation based on their systemic effects and 
outcome. 
The present study was designed to assess and compare the hemodynamic 
effects of 2% lignocaine with adrenaline in concentrations of 1: 80000 & 1: 2, 00,000 
during routine dental extractions in normal healthy individuals. 
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AIMS 
The aim of this study was to quantitatively assess different hemodynamic 
parameters during minor oral surgical procedures under local anaesthesia without the 
use of adrenaline and with adrenaline at different concentrations of 1:80,000 and 
1:2,00,000. 
OBJECTIVES 
The present study was designed to compare the hemodynamic parameters 
during administration of local anaesthetics agent lignocaine 2% without adrenaline 
and with adrenaline in different concentrations such as 1:80,000 and 1:2, 00,000 in 
minor oral surgical procedures with regard to: 
1. Systolic blood pressure. 
2. Diastolic blood pressure. 
3. Heart rate. 
4. Oxygen saturation. 
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Vernale et al7 in 1962 investigated the cardiovascular effects of injection of 
2% lignocaine with and without epinephrine 1:100,000 in normotensive and 
hypertensive subjects. This study revealed that the cardiovascular responses of the 
hypertensive patients differed from that of the normal subjects. A rise in the systolic 
pressure and heart rate and a slight rise or fall in the diastolic pressure was noticed in 
normotensive and hypertensive group. Hypertensive patients reacted more vigorously 
to pressor stimuli. He concluded that no significant variations in cardiovascular 
responses in blood pressure, heart rate, and ECG complex were produced by injection 
or extraction in either the control or the epinephrine treated groups of both 
normotensive and hypertensive patients. 
Stannard et al8 in 1968 evaluated the hemodynamic effects of lignocaine 
during acute myocardial infarction. A 100 mg of lignocaine was administered over a 
period of 5 min in patients with myocardial infarction within 24 hrs. No statistically 
significant change in blood pressure was seen before and after administration of 
lignocaine. Hence they concluded that lignocaine is a safe drug to be used in 
ventricular arrhythmias complicating acute myocardial infarction. 
Christensen et al9 in 1980 measured blood pressure intra-arterially after 
subcutaneous infiltration of 15-20 ml of 0.5% lignocaine with nor adrenaline 
(1microgram/ml) in 20 patients aged 24-73 who were scheduled for craniotomy. In 
this study SBP went up to 125% of the pre injection values, reaching a maximum 
seven minutes after injection. Within 20 minutes, the blood pressures fell to 105% of 
pre injection values. They concluded that use of adrenaline should be considered an 
additional hazard to patients undergoing neurosurgical operations.  
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Goldstein et al10 in 1982 studied the circulatory, physiological and plasma 
catecholamine responses during third molar extractions and the effect of sedation 
with intravenous diazepam and inclusion of epinephrine in local anaesthetic. The HR 
and SBP increased significantly in all patients and no change in DBP was seen. Non 
sedated patients showed a 60% rise in plasma nor epinephrine concentration.  
Administration of local anaesthetic containing epinephrine resulted in a rise in mean 
plasma epinephrine by 5 minutes after injection. The results suggested the 
involvement of sympathetic nervous system in producing circulatory responses in 
dental surgery.  
Chernow et al11 (1983) conducted a randomized double-blind crossover trial 
to define the hemodynamic effects of local anaesthesia during dental procedures. The 
mean arterial pressure (MAP), heart rate, and plasma catecholamine responses for 60 
minutes following an inferior alveolar nerve block with epinephrine and 
norepinephrine-containing lignocaine hydrochloride in 14 men were measured. The 
results showed that lignocaine alone caused no significant change in mean arterial 
pressure  or heart rate and only slight, transient changes in plasma catecholamine 
concentrations when compared with baseline values. Lignocaine with epinephrine 
caused significant, sustained increases in plasma epinephrine concentrations and a 
slight, but transient increase in heart rate from 68 to 70 beats per minute. Lignocaine 
with epinephrine caused no significant change in MAP. They concluded that there is 
no significant hemodynamic response to lignocaine dental anaesthesia with or without 
epinephrine in healthy young men.    
Emanuel S. Troullos, (1986)12 evaluated the effects of administering an 
epinephrine-containing local anaesthetic on plasma catecholamine levels and 
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cardiovascular parameters. Significant elevations were observed following 
administration of 8 dental cartridges of 2% lignocaine with epinephrine 1:100,000 
(144 µg). Minimal changes were observed in the patients who received 6 cartridges of 
3% mepivicaine. One minute after injection, the mean plasma epinephrine level in the 
group receiving epinephrine was 27 times higher than baseline. There was significant 
elevation in systolic blood pressure and pulse rate with the epinephrine group. No 
significant change in diastolic pressure was seen. These results indicate that 
significant amounts of epinephrine can be systemically absorbed following intraoral 
injection and the absorbed epinephrine can alter the cardiovascular status of the 
patient.    
Meyer F U13 in 1986 conducted a prospective randomised study of 
hemodynamic changes of normotensive and hypertensive groups undergoing 
extraction procedures under 2% lignocaine with and without 1:100,000 epinephrine. 
No significant differences were noticed between the groups in evaluated 
hemodynamic parameters. He reported that in both groups the changes of blood 
pressure and heart rate were similar.   
Abraham14 in 1988 studied changes in the cardiovascular system before, 
during, and after treatment for 40 patients undergoing extractions. He found that 
patients with hypertension undergoing dental extractions had a greater increase in 
blood pressure than normotensive patients after injection of 2% lignocaine with 
1:80,000 epinephrine. In addition, 7.5% of the patients with hypertension developed 
significant arrhythmias.   
Salonen et al15 in 1988 conducted a double-blind, cross-over study to evaluate 
the role of adrenaline 1:80,000 in lignocaine used in dental local anaesthesia on 
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hemodynamics and plasma catecholamine levels. The exogenous adrenaline 
significantly elevated the heart rate, but did not affect systolic or diastolic blood 
pressure. They conclude that the adrenaline present in the local anaesthetic is a major 
source of adrenergic activation during minor oral surgery.  
Niwa et al1 in 1991 compared the effects of infiltration injection of 3.6 mL 
lignocaine with either 1:80,000 epinephrine or 1:25 norepinephrine. It was concluded 
that epinephrine activates left ventricular diastolic function and in contrast 
norepinephrine impairs it.   
Meechan et al16 in 1992 studied metabolic responses to oral surgery under 
local anaesthesia and sedation with two different local anaesthetics. The patients were 
randomly given 4.4 mL of 2% lignocaine with 1: 80,000 epinephrine in one group 
and 4.4 mL of 3% prilocaine with 0.03 IU/mL felypressin in other group. The 
epinephrine-containing local anaesthetic reduced the plasma potassium concentration 
at 10 min after injection and increased the blood glucose concentration.  Plasma 
potassium increased and blood glucose decreased following the administration of the 
epinephrine free solution. So they concluded that epinephrine-free and epinephrine 
containing local   anaesthetics differs in their metabolic effects during oral surgery.  
Peruse et al17 in 1992 did a literature review regarding the contraindications to 
vasoconstrictors in dentistry. It was suggested that the absolute contraindications 
include heart diseases such as unstable angina, recent myocardial infarction, recent 
coronary artery bypass surgery, uncontrolled hypertension, diabetics, 
hyperthyroidism, sulphite sensitivity and pheochromocytoma. The relative contra 
indications include patients under tricyclic anti depressants, phenothiazine 
compounds, monoamine oxidase inhibitors, non-selective beta blockers and cocaine 
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abusers.  They concluded that complications occurring after administration of local 
anaesthetics with vasoconstrictors are not exclusive for patients with severe 
cardiovascular disease.  
Middlehurst 18 in 1999 investigated hemodynamic and electrocardiographic 
responses to lignocaine 2%, noradrenalin 1:50,000, vasopressin 0.25 IU/mL, and 
midazolam. There was statistically significant changes in the individual parameters of 
mean heart rate and mean systolic blood pressure with the administration of 
anaesthetic. The values were rising from a baseline value to a peak and then falling. 
But on considering statistically significant changes to the mean values for HR and 
SBP for both anaesthetic and sedation groups, the physiological  magnitude and 
clinical relevance of such change would be described as minimal.  
Homma et al19 in 1999 studied the relationship between oral mucosal blood 
flow and plasma epinephrine levels after sub mucosal epinephrine injections. Patients 
were administered with 2% lignocaine with adrenaline submucosally. Plasma 
epinephrine concentration, SBP, DBP and HR were recorded before and after 
infiltration. There was an increase in plasma epinephrine concentration which peaked 
by 3min after infiltration.  A correlation was present between base line mucosal blood 
flow and maximum increase in plasma epinephrine concentration. There were no 
significant differences in the hemodynamic changes.  This result suggests that plasma 
epinephrine concentration after sub mucosal infiltration is dependent on the initial 
mucosal blood flow in the injected areas.  
Yagiela et al 20 in 1999 reviewed the literature on drug interactions associated 
with vasoconstrictors in dental practice involving tricyclic antidepressants, 
nonselective β-adrenergic blocking drugs, certain general anaesthetics and cocaine. 
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Tricyclic antidepressants block muscarinic and α1-adrenergic receptors and directly 
depress the myocardium. These actions can additionally modify cardiovascular 
responses to the vasoconstrictors.  Use of epinephrine in halothane anaesthesia was 
associated with ventricular dysrythmias. In case of cocaine abusers, cocaine may 
enhance adrenergic neurotransmitter release and postsynaptic responses are 
intensified to epinephrine like drugs. Hence vasoconstrictors should be with held for 
at least 24 hours after cocaine exposure to allow for elimination of the drug and its 
active metabolites. In conclusion, careful administration of small doses of 
vasoconstrictors, coupled with monitoring of vital signs, will permit these drugs to be 
used with only minimal risk.  
Niwa et al21 in 2000 investigated the hemodynamic response to infiltration 
anaesthesia and epinephrine infusion and compared these responses with those 
produced by ergo meter exercise. The study subjects were given epinephrine 
infusions to produce cardiovascular response comparable to those seen in lignocaine 
– adrenaline (1:80,000) infiltration anaesthesia. The cardiovascular response to this 
drug was evaluated using echocardiography and compared to those produced by ergo 
meter exercise. The results revealed that the cardiovascular response to infiltration 
anaesthesia is minimal and is equivalent to walking at a speed of 4.8 km/hr. So it was 
concluded that except in certain pathologic conditions such as serious arrhythmia, 
infiltration anaesthesia can be carried out safely.  
Tanaka et al22 in 2000 evaluated the efficacy of hemodynamic criteria for 
detecting intravascular injection of epinephrine. Patients under general anaesthesia 
were given epinephrine test dose of 15 micro grams. HR, BP and ECG were recorded 
before and after administration of test dose. Compared to pre-injection values, 
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injection of epinephrine test dose produced significant increase in HR between 40–
80seconds. A significant decrease in HR was seen between 160–280seconds. A 
significant, monophasic increase in SBP were seen between 20–240seconds. These  
results indicated that a minimal effective epinephrine dose for detecting unintentional 
intravascular injection of epinephrine was 15 micrograms creating > 10 beats/min 
increase in HR and the SBP > 15 mmHg than baseline values.   
Meechan et al 23 in 2001 performed a randomised, single-blind, cross-over 
study to evaluate the hemodynamic effects of 2% lignocaine with 1:80,000 
epinephrine and 3% prilocaine with  felypressin. There was an increase in heart rate 
10 minutes following the injection of the epinephrine-containing solution and fall in 
diastolic blood pressure  20 minutes after injection of lignocaine with epinephrine.  
Niwa H et al24 in 2001 conducted a study to examine the safety of 
epinephrine-containing local anaesthesia for use on patients having cardiovascular 
disease with impedance cardiology to determine hemodynamic responses to an 
injection of 1.8 mL of 2% lignocaine with 1:80,000 epinephrine. The conclusion was 
that lignocaine-epinephrine was safe and had few, if any, hemodynamic consequences 
in patients with cardiovascular disease.  
Fernieini M et al25 in 2001 compared the hemodynamic effects of local 
anaesthetics with or without adrenaline using laser doppler flowmetry. The heart rate 
increased in plain lignocaine and lignocaine with adrenaline group just before 
administration and returned to normal immediately after injection. Again a significant 
increase in HR was seen in epinephrine group 5min post injection and persisted to 10 
min post injection with the epinephrine containing LA in this study.  The author 
suggested the pre injection rise in HR was a result of endogenous release of 
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catecholamine. The delayed increase in the HR in adrenaline group was due to 
adrenaline contained in local anaesthetics.  
Niwa et al26 in 2001 evaluated hemodynamic responses to intraoral injection 
of lignocaine with 1:80 000 adrenaline with impedance cardiograph to examine their 
safety on patients with cardio vascular disorders. In this study the SBP and HR was 
increased by 4.1% and 5.1%. DBP remained unchanged. None of the patients had any 
cardiac symptoms and no significant response related to the extent of cardiac 
functional capacity. They concluded that lignocaine epinephrine was safe with 
minimal hemodynamic consequences in patients with cardio vascular disorders. 
Ohkado et al27 in 2001 compared the anaesthetic potency of lignocaine and 
epinephrine in different concentrations. Anaesthetic potency on dental pulp was 
investigated by changing the concentration of lignocaine and that of epinephrine. The 
results showed that a decrease in the epinephrine concentration produced a decrease 
in the anaesthetic potency independent of lignocaine concentration. It was concluded 
that an increase in lignocaine concentration may not compensate the decrease in 
epinephrine concentration.  
Murthy and Rao28 in 2001 investigated cardiovascular responses to infiltration 
of the scalp with five different combinations of epinephrine and lignocaine. Group A 
being lignocaine 0.5%; Group B- lignocaine 0.5% with epinephrine 1:200,000; Group 
C - lignocaine 0.5% with epinephrine 1:100,000; Group D- normal saline with 
epinephrine 1:200,000; and Group E- normal saline with epinephrine 1:100,000. Plain 
lignocaine did not cause any significant change in blood pressure. The systolic, 
diastolic, and mean arterial hypertension was significantly increased in group E. 
Episodes of diastolic hypertension occurred frequently in Group D. A biphasic 
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diastolic and mean arterial hypotension by around minute 2 and minutes 9-15 
occurred in both Groups C and B. In conclusion, epinephrine in concentrations of 
1:100,000 and 1:200,000 causes significant tachycardia and hypertension. The 
combination of lignocaine and epinephrine attenuates the hypertension but results in a 
biphasic hypotensive response.   
Bader et al29 in 2002 conducted a review of cardiovascular effects of 
epinephrine on hypertensive dental patients. The results revealed that epinephrine use 
in hypertensive patients is associated with increase in SBP for 4 mmHg and no higher 
for normotensive subjects. HR was higher in patients receiving epinephrine than that 
with plain lignocaine group and DBP was found to decrease for both normotensive 
and hypertensive individuals.  
Faraco et al6 in 2003 conducted a double blind study to evaluate 
cardiovascular parameters during dental procedures. The parameters included SBP, 
DBP, and mean blood pressures, and heart rate. The patients were divided into 3 
groups. One group received no premedication. Group 2 with 10 mg diazepam, and 
group 3 premedicated by a placebo. All patients received 1.8 mL of 2% lignocaine 
with epinephrine 1:100,000. There were no changes in the parameters evaluated 
during the clinical procedures.  They concluded that there is no change in the 
cardiovascular parameters with pre medication during dental procedures.  
Yang JJ et al30 carried out a prospective, randomized; double-blinded study to 
discover the hemodynamic effects after local infiltration of 1:200,000 adrenaline 
contained in 2% lignocaine under general anaesthesia. It revealed Lignocaine 2% or 
saline with adrenaline (1:200,000) does cause temporary hypotension and other 
hemodynamic changes during general anaesthesia, which last no longer than 4 
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minutes. This mechanism was attributed to the preferential stimulation of the beta 2 
receptors at lower concentrations of adrenaline.   
Gedik et al31 in 2005 investigated changes in blood pressure, pulse rate and 
temperature before and after periodontal surgery. A decrease in BP, HR and 
temperature were observed during administration of local anaesthetic containing 
0.06mg adrenaline. They concluded that factors such as patient age, gender, volume 
of local anaesthetic, the length of the treatment and the difficulty of the procedure 
may be determinants of the change in blood pressure. All the parameters that showed 
significant changes only in medically compromised patients.  
Meral et al32 in 2005 conducted a randomised cross over comparison to 
determine the effects of lignocaine with or without adrenaline on plasma epinephrine 
concentrations and hemodynamic changes during third molar surgery. The results 
revealed there is no significant change in the SBP or DBP or saturation  in both 
groups. The plasma epinephrine values were higher in lignocaine with adrenaline 
group. He concluded that local anaesthetic with adrenaline has minimal 
hemodynamic consequences on third molar surgeries.  
Haghighat et al33 in 2006 evaluated hemodynamic effects of 2% lignocaine 
with 1:80,000 epinephrine in inferior alveolar nerve block. Systolic blood pressure 
was raised during the injection, but 10 minutes later, it was lower than that during 
injection. A decrease in diastolic blood pressure was noticed at the end of injection 
and 10 minutes after injection. He suggested that the increase of BP at the beginning 
of dental operation was probably due to stress.  Considerable decrease in diastolic BP 
after injection could be because of decrease in dental syringe phobia after local 
anaesthesia infiltration. Findings of this study showed that one cartridge of lignocaine 
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with epinephrine has minimal clinical effects on BP, and the prescribed dosage is 
without any severe hemodynamic effect on healthy patient.  
Niwa et al34 2006 studied the cardiovascular effects of epinephrine under 
sedation with nitrous oxide, propofol, or midazolam. Hemodynamic response and 
blood pressure and heart rate were measured. When epinephrine was infused alone, 
heart rate (HR) and cardiac index (CI) increased. Propofol suppressed the 
epinephrine-induced increase in CI. In case of midazolam infusion, the highest dose 
of adrenaline caused a significant increase in HR, which was significantly higher than 
for epinephrine infusion alone. Nitrous oxide has no influence on the cardiovascular 
response to epinephrine. They concluded that increased cardiovascular activity due to 
epinephrine can be alleviated by propofol.  
Yang et al35 in 2006 conducted a prospective randomized double blind study 
to observe hemodynamic changes caused by local infiltration of epinephrine 
containing lignocaine solution on nasal field under GA. This study showed local 
infiltration of epinephrine-containing lignocaine solution on nasal field causes 
significant decrease in mean arterial pressure and increase in HR. The explanation 
was the hemodynamic effects of epinephrine are dose-dependent and different dose of 
epinephrine may activate different types of sympathetic receptors. A rate of 1 to 
2µg/min predominantly activates β2-receptors with resulting vascular and bronchial 
smooth muscle relaxation and a rate of 2 to 10 µg/min predominantly activate β1-
receptors to increase heart rate, contractility, conduction and decrease the refractory 
period. Doses in excess of 10 µg/min cause marked α-stimulation with resultant 
generalized vasoconstriction. The hemodynamic changes after local infiltration of 
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epinephrine depend on physical status of the individual, epinephrine dose used, 
vascularity of the site of administration and its rate of absorption from infiltrated area.  
Faraco et al36 in 2007 conducted a study to evaluate cardiovascular changes 
during dental implant surgery. It was done using 2% lignocaine with 1:80,000 
epinephrine. The patients were monitored in the preoperative, intraoperative, and 
postsurgical periods by continuous non-invasive automatic arterial pressure and heart 
rate measurements taken every 2 minutes.  No significant change in the evaluated 
parameters was noticed. They concluded that there were no changes in the analyzed 
cardio circulatory parameters during dental implant surgery in relation to systolic, 
diastolic, and mean arterial blood pressures and heart rate in normotensive subjects 
anesthetized with 2% lignocaine with epinephrine 1:80,000.    
Liau et al37 in 2008 evaluated the cardiovascular response to dental anxiety 
during local anaesthesia for dental procedures. BP, HR, SPO2 and ECG changes were 
measured before and after the administration of anaesthetic. Anxiety was measured 
15 minute before the procedure using Corah’s Dental anxiety scale. Patients with 
mild dental anxiety had lower HR than those with moderate or severe dental anxiety. 
After local anaesthetic administration, HR increased in all patients and the increase 
was greater in severe dental anxiety group. The increase in SBP was greater in severe 
dental anxiety group than others. No significant change in oxygen saturation was 
noticed. This suggests that dental anxiety impacts the effect of delivery of local 
anaesthesia on BP and heart rate.   
Ricardo et al38 in 2008 conducted a double-blind randomized clinical trial to 
examine the effect of four different local anaesthetics of the amide group in patients 
undergoing extraction of lower third molars and verified the changes in systolic, 
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diastolic and mean blood pressures, heart rate (HR) and oxygen saturation (SPO2). It 
was seen that all the anaesthetics produced an increase in HR.  The variations in BP, 
HR and SPO2 returned to normal without the need for any additional treatment. So 
they concluded that local anaesthetics, when used in dentistry, produce limited and 
safe hemodynamic effects. 
Moshaver et al39 in 2009 conducted a double-blind, randomized clinical trial 
to assess the hemodynamic and haemostatic effects of 2 different concentrations of 
epinephrine in local anaesthetic used during functional endoscopic sinus surgery. 
Baseline and post injection hemodynamic parameters were recorded at 1-minute 
intervals for 5 minutes. Hemodynamic and haemostatic parameters and intraoperative 
blood loss were compared. Significant hemodynamic fluctuations were noted 
following injection of lignocaine, 2%, with 1:100 000 epinephrine. Increase in heart 
rate and systolic, diastolic, and mean arterial blood pressure were noted in 1:100 000 
epinephrine group. The increase was found to be significant in the first and second 
minutes after injection and decreased to baseline level by the fifth minute. This 
fluctuation was not noted in patients, who received lignocaine, 2%, with 1:200000 
epinephrine.    
Laragnoit et al40 in 2009 conducted a randomised clinical trial to analysed the 
hemodynamic changes in patients with cardiac diseases undergoing dental treatment 
under local anaesthesia with 2% lignocaine and adrenaline 1:2.00.000. Patients were 
divided into two groups. One group received plain lignocaine and the other group 
received lignocaine with adrenaline. No difference in SBP, DBP and HR were noticed 
before and after administration of local anaesthetic between the two groups. They 
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concluded that administration of local anaesthetic with adrenaline in cardiac valvular 
disease patients did not cause any arrhythmic or cardiovascular changes. 
Marcelo et al41 in 2010 evaluated glucose levels and hemodynamic changes in 
patients during routine dental treatment with and without local anaesthesia. 
Hemodynamic parameters, including SBP, DBP, HR, and glucose levels did not 
change significantly regardless of whether local anaesthesia was used. He explained 
the reason for no change in hemodynamic parameters that adrenaline has both beta 1 
and beta 2 activity. Beta 1 stimulation causes an increase in blood pressure, whereas 
beta 2 stimulation decrease blood pressure.  
Tariq et al42 in 2010 conducted a comparative study to find  out  changes in 
the  systolic  blood  pressure, heart rate, and  diastolic  blood  pressure  after 
infiltrating scalp with adrenaline with  or without Lignocaine.  One group received 
lignocaine 2% with adrenaline  1:200,000  and  group 2  received  normal saline with  
adrenaline 1:200,000. Tachycardia was seen more frequently in second group.  SBP, 
DBP and mean arterial pressure were significantly increased in group 2.  Significant 
decrease in DBP occurred in group 1. This showed that scalp infiltration of adrenaline 
alone will cause significant hypertension. The addition of lignocaine decrease in 
blood pressure.  
Goranovic et al43 in 2011 conducted a retrospective, comparative, non-
randomised, study to determine the effect of injection speed of adrenaline- containing 
lignocaine solution on hemodynamic changes during local infiltration of nasal 
mucosa under general anaesthesia. There was no significant difference in HR, SAP, 
DAP nor MAP during either slow (< 60seconds) or fast (> 60seconds) injections. 
However lignocaine with adrenaline induced a decrease of blood pressure.  
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Vnuk et al44 in 2011 evaluated hemodynamic effects of epidural lignocaine 
and lignocaine-adrenaline in dogs. It was noticed that heart rate and cardiac output 
increased significantly in adrenaline compared to baseline values. There was a 
decrease in arterial and pulmonary artery pressure in plain lignocaine group. They 
suggested that addition of adrenaline to lignocaine is associated with positive effects 
of adrenaline in preventing hypotension. But because of the potential hazards of 
increase in heart rate and cardiac output especially in elderly, the routine use of 
epidural adrenaline should be reconsidered in patients with high hemodynamic risk. 
Silvestre et al45 in 2011 carried out a prospective observational study to 
evaluate the safety of local anaesthesia during dental extraction in hypertensive 
patients.  Blood pressure, heart rate and oxygen saturation were measured before and 
after administration of articaine with 4% epinephrine in one group and mepivacaine 
in another group. In the vasoconstrictor group, there was a rise in SBP and HR three 
minutes after the administration of LA. But it was not statistically significant. These 
values returned to normal after the procedure was completed.  They concluded that 
during procedures such as dental extractions, no significant hemodynamic changes 
were seen in well controlled hypertensive patients   attributable to anaesthetics with 
vasoconstrictors. 
Ogunlewe et al46 in 2011 conducted a prospective study to evaluate the 
changes in blood pressure and the pulse rate of patients with controlled hypertension 
receiving dental extraction under local anaesthesia using lignocaine with adrenaline, 
and to evaluate whether these changes were are attributable to addition of adrenaline. 
There was a increase in SBP following injection in both groups but fell to the same 
level that is slightly lower than the pre-anaesthetic value. The rise in BP was 
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significantly higher in plain lignocaine group which may be a result of impaired pain 
control from less effective anaesthesia with plain lignocaine.  
 Chaudhry et al47 in 2011 evaluated the effect of epinephrine containing dental 
local anaesthetic on BP and pulse rate in hypertensive patients. All patients received 
3.6  ml of 2% Lignocaine with 1:100,000 epinephrine. A decrease in systolic in stage 
2 hypertension patients after 2 and 5 minutes of injections was noted. The DBP fell in 
all the groups after injections.  
Sivanmalai et al48 in 2012 conducted a prospective randomised clinical study 
to investigate the hemodynamic effects of adrenaline in lignocaine in clinical doses 
during third molar surgery under local anaesthesia. No significant change in heart rate 
or blood pressure was noted during the study. But there was a rise in plasma 
potassium and blood glucose concentration 20 min after administration of lignocaine 
with adrenaline.   
Ketabi M et al49 in 2012 conducted a randomized double-blind clinical trial 
comparing the changes in HR and BP after administration of lignocaine with and 
without epinephrine. In this study, the mean systolic and diastolic BP and HR was 
reduced after injection of lignocaine without epinephrine. After administration of 
lignocaine with adrenaline, the mean systolic and diastolic BP and HR was found to 
increase.  
Daniel et al50 in 2012 compare cardiovascular safety profiles of two dental 
anaesthetics, articaine versus standard mepivacaine solutions used during periodontal 
treatment in cardiovascular patients. A rise in HR, SBP and DBP were noticed in 
local anaesthetics with adrenaline group when compared to those without adrenaline. 
Oxygen saturation did not show any significant alterations. He concluded that the 
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administration of anaesthetics containing vasoconstrictors in patients with 
cardiovascular diseases should be done with caution.  
Miratashi et al51 in 2012 conducted a double blinded  randomized clinical trial 
to evaluate hemodynamic effects of intraocular epinephrine irrigation during cataract 
surgery.  Patients were randomly allocated into two groups with one group receiving 
intraocular irrigation fluid (balanced salt solution) with epinephrine 1:1,00,000 and 
the control group received plain intraocular irrigation fluid. Heart rate (HR), systolic 
and diastolic blood pressure (SBP, DBP) were measured before and at 5, 10, 15 
minutes in both groups. DBP was decreased at 5 minutes after administration in the 
epinephrine group and increased at 10 and 15 minutes. There were no significant 
differences noticed between the two groups. So they concluded that the use of 
epinephrine 1: 1,00, 000 has minimal hemodynamic effects. 
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This is a prospective, randomised controlled study. Patients who reported to 
the Department of Oral and Maxillofacial Surgery, Sree Mookambika Institute of 
Dental Science, Kulasekharam K.K district, Tamilnadu were included in the study. 
Thirty patients who satisfied the required criteria formed the study sample. 
INCLUSION CRITERIA: 
 Patients willing to take part in the study. 
 Patients who require multiple mandibular minor oral surgical procedures 
under local anaesthesia through inferior alveolar nerve block. 
 Patients who fulfil ASA (American Society of Anaesthesiologists) Grade 1 
criteria. 
 Patients over 18 years of age. 
EXCLUSION CRITERIA: 
 Patients who do not fulfil ASA grade 1 criteria. 
 Patients who have a positive history of pheochromocytoma, hyperthyroidism, 
asthma, hypertension or any other cardio respiratory disorders. 
 Patients who are under tricyclic anti depressants, MAO inhibitors and anti 
hypertensive drugs. 
 Patients with known allergy to local anaesthetic drugs. 
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MATERIALS USED  
 Multi parameter monitor ( BPL EXCELLO Eco, BPL -India) 
 3 ml single use syringe ( Dispovan, Hindustan Syringes and Medical Devices, 
India)  
 26 gauge needle ( Dispovan, Hindustan Syringes and Medical Devices, India)  
 Lignocaine 2% (Zelcaine 2%, Bio Medica Laboratories, India) 
 Lignocaine 2%   adrenaline 1:80,000 (Lignox 2% A 1:80,000, Indoco 
Remedies, Indore, India) 
 Lignocaine 2%  adrenaline 1:2,00,000 (Xylocaine 2% Adrenaline (1:2,00,000) 
, Astra Zeneca, India) 
 Topical lignocaine 2% (Lox 2% gel, Neon laboratories, India) 
Zelcaine 2%, Lignoxox 2% adrenaline 
1:80,000 
Xylocaine 2% 
Adrenaline 1:2,00,000 
Lignocaine Hydrochloride 
20.0 mg 
Lignocaine Hydrochloride 
24.64 mg 
Lignocaine Hydrochloride 
21.3 mg 
Sodium Chloride 
6mg 
Adrenaline Bitartrate 
0.0125 mg 
Adrenaline Bitartrate 
0.005 mg 
Methylparaben 
1.0 mg 
Methylparaben 
1 mg 
Sodium metabisulphite 
0.5mg 
Water for injection 
1.0ml 
Water for injection 
 
Sodium Chloride 
6mg 
  Water for injection 
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Procedure  
All Patients who satisfied the pre requisites were well informed regarding 
conduct of the procedure, and an informed written consent was obtained. Using a 
repeated - measure design, each subject was administered with  local anaesthesia prior 
to the desired procedure. The various anaesthetic solutions tested included plain 
Lignocaine 2%, Lignocaine 2% with adrenaline 1:80,000 and Lignocaine 2% with 
adrenaline 1: 2, 00,000 forming group I, .group II, group III respectively. The 
sequence of solution administration was determined randomly, and all the injections 
were performed by a single operator. During each appointment a single agent was 
administered and on subsequent appointments, the choice of agent differed in terms of 
their adrenaline concentrations. Every appointment was spaced one week apart, 
totalling 3 visits for each patient. 
During each visit, prior to injection of local anaesthesia, systolic blood 
pressure, diastolic blood pressure, heart rate and oxygen saturation were noted using a 
multi-parameter monitor with the patient in a semi reclined position. The instrument 
was automated and had monitors for non invasive blood pressure and pulse oximetry. 
It had a measure strip of 10 mmHg to 300 mmHg for systolic blood pressure, 10 
mmHg to 300mmHg for diastolic blood pressure, 10 beats/min to 300 beats/min for 
heart rate and 0% to 100% for oxygen saturation. The BP cuff was connected to one 
arm and pulse oximeter probe was connected to the other hand index finger. 
All patients were categorised into groups based on the choice of local 
anaesthetic agent used with their respective concentration of adrenaline. The total no. 
of groups being three, group I included patients who received plain Lignocaine 2%, 
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group II received Lignocaine 2% with adrenaline 1:80,000 and group III received 
Lignocaine 2%  with adrenaline 1:2, 00,000. 
Before local anaesthetic administration, all patients received topical 
anaesthesia at the injection site using 2% lignocaine topical preparation. A standard 
inferior alveolar nerve block was administered using a disposable aspirating type 
syringe and 26 gauge long needle. Aspiration was performed after needle insertion 
and before deposition of anaesthetic solution to avoid inadvertent intravascular 
injection. Injection was done slowly at a rate of 1ml per minute. All patients received 
1.8 ml of local anaesthetic solutions during each appointment.  
Under each group, the following parameters such as oxygen saturation, heart 
rate systolic and diastolic blood pressure were recorded immediately after 
administration and  at timely intervals of 5 min, 10 min, 15 min, 20 min and 30 min. 
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Case History Proforma 
 
Name     :  
Age/Sex    :  
O.P.No    :  
Address    : 
Chief complaint      :   
History of Present Illness (HOPI) :  
 
Past Medical History  : 
 
Past dental History   : 
History of drug allergy  :   
Habit     : 
Family history   : 
Extra/Intra oral   Examination : 
Provisional Diagnosis  : 
Treatment done   : 
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Group I 
SPO2 
Sl.No. Before 
Administration Immediate 5min 10min 15min 20min 30min 
1-30        
 
HEART RATE  
Sl.No. Before 
Administration Immediate 5min 10min 15min 20min 30min 
1-30        
 
BLOOD PRESSURE  
S.N 
 
Before 
administration 
Immediate 5 min 10 min 15 min 20 min 30 min 
SBP DBP SBP DBP SBP DBP SBP DBP SBP DBP SBP DBP SBP DBP 
1-
30 
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Group II 
 
 
SPO2 
Sl.No. Before 
Administration Immediate 5min 10min 15min 20min 30min 
1-30        
 
HEART RATE  
Sl.No. Before 
Administration Immediate 5min 10min 15min 20min 30min 
1-30        
 
BLOOD PRESSURE  
S.N 
 
Before 
administration 
Immediate 5 min 10 min 15 min 20 min 30 min 
SBP DBP SBP DBP SBP DBP SBP DBP SBP DBP SBP DBP SBP DBP 
1-
30 
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Group III 
SPO2 
Sl.No. Before 
Administration Immediate 5min 10min 15min 20min 30min 
1-30        
 
HEART RATE  
Sl.No. Before 
Administration Immediate 5min 10min 15min 20min 30min 
1-30        
 
BLOOD PRESSURE  
S.N 
 
Before 
administration 
Immediate 5 min 10 min 15 min 20 min 30 min 
SBP DBP SBP DBP SBP DBP SBP DBP SBP DBP SBP DBP SBP DBP 
1-
30 
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Figure I – Materials used 
 
 
 
 
 
 
 
 
 
 
Figure II- Administration of local anaesthesia 
Results 
 
 26 
 
 The hemodynamic changes on administration of plain lignocaine and 
lignocaine with different concentrations of adrenaline were recorded using a multi 
parameter monitor. The SPO2, SBP and DBP for Group-I, Group-II, Group-III at 
different time periods were recorded and tabulated as shown in table 1,2,3,4,5,6,7,8,9. 
The mean valued are shown in tables 10, 11, 12 and 13 
Table-1: Effect of lignocaine 2% on SPO2 
Table-2: Effect of lignocaine 2% on Heart rate  
Table-3: Effect of lignocaine 2% on Blood pressure  
Table-4: Effect of lignocaine 2% with adrenaline 1:80,000 on SPO2 
Table-5: Effect of lignocaine 2% with adrenaline 1:80,000 on heart rate 
Table-6: Effect of lignocaine dilution 1:80,000 blood pressure 
Table-7: Effect of lignocaine 2% with adrenaline 1:2,00,000 on SPO2 . 
Table-8: Effect of lignocaine 2% with adrenaline 1:2,00,000 on heart rate 
Table-9: Effect of lignocaine 2% with adrenaline 1:200000 on Blood pressure 
Table-10: Mean values of SPO2  in different groups  
Table-11: Mean values of heart rate in different groups 
Table-12: Mean values of systolic blood pressure in different groups 
Table-13: Mean values of diastolic blood pressure 
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TABLES 
Group-I : Lignocaine 2% 
Table-1: Effect of Lignocaine 2% on SPO2 
S.NO Before Administration Immediate 05 min 10 min 15 min 20 min 30 min 
1 98 98 97 98 97 98 98 
2 99 96 98 99 99 99 98 
3 99 96 98 98 98 98 98 
4 97 95 94 95 96 99 98 
5 98 98 98 98 98 98 94 
6 98 98 98 98 98 98 98 
7 98 98 98 98 98 98 98 
8 98 98 97 98 97 98 98 
9 99 96 98 99 99 99 98 
10 99 96 98 98 98 98 98 
11 97 95 94 95 96 99 98 
12 98 98 96 98 98 98 94 
13 98 98 98 98 98 98 98 
14 97 98 98 98 98 96 97 
15 98 99 97 98 97 98 98 
16 99 96 96 99 99 99 98 
17 97 96 98 98 97 98 98 
18 97 95 94 95 96 99 98 
19 98 97 98 96 98 98 74 
20 93 98 99 98 98 97 95 
21 98 95 98 98 99 99 98 
22 93 95 96 98 97 99 98 
23 99 96 98 99 99 99 98 
24 99 96 98 98 98 98 98 
25 97 95 94 95 96 99 98 
26 98 98 98 98 98 98 94 
27 98 98 98 98 98 98 98 
28 98 98 98 98 98 98 98 
29 98 98 97 98 97 98 98 
30 99 96 98 99 99 99 98 
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Table-2: Effect of Lignocaine 2% on Heart Rate 
S.NO Before Administration Immediate 05 min 10 min 15 min 20 min 30 min 
1 58 50 58 59 59 61 66 
2 99 91 89 86 88 98 98 
3 74 71 86 73 71 74 73 
4 77 75 74 75 76 79 78 
5 83 81 84 79 84 83 80 
6 98 98 102 102 103 105 101 
7 83 81 84 84 79 83 80 
8 58 50 59 59 59 61 66 
9 98 91 89 86 88 98 98 
10 75 71 85 73 71 74 73 
11 78 75 74 74 76 79 78 
12 82 81 84 79 84 83 80 
13 99 98 102 102 103 105 100 
14 75 79 85 84 80 81 80 
15 58 50 58 59 59 61 65 
16 99 91 90 87 88 98 99 
17 75 71 86 74 71 75 74 
18 77 75 74 75 76 79 78 
19 82 81 85 78 84 81 80 
20 98 98 100 102 103 105 101 
21 81 81 82 85 79 83 79 
22 54 49 58 59 59 67 65 
23 98 91 89 87 82 98 99 
24 77 71 86 73 71 73 74 
25 78 75 74 75 77 79 78 
26 80 80 84 78 84 83 79 
27 99 99 102 102 103 105 101 
28 74 75 85 85 79 80 81 
29 59 49 58 59 60 63 66 
30 90 90 89 86 88 99 99 
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Table-3: Effect of Lignocaine 2% on Blood pressure 
.NO  
Before 
Administration 
Immediate 05 min 10 min 15 min 20 min 30 min 
SBP DBP SBP DBP SBP DBP SBP DBP SBP DBP SBP DBP SBP DBP 
1 120 70 111 64 114 74 117 73 114 70 112 66 111 65 
2 118 83 123 90 120 86 120 87 122 86 117 78 116 83 
3 117 72 115 72 122 80 116 70 117 74 114 72 115 74 
4 103 69 104 64 105 65 102 68 103 58 102 65 101 65 
5 123 81 131 80 117 77 124 76 118 73 114 80 125 82 
6 127 79 121 77 133 84 116 79 126 77 120 79 117 76 
7 125 81 133 80 119 77 126 76 120 73 124 83 124 82 
8 120 70 111 64 114 74 117 73 115 70 112 66 111 65 
9 119 84 123 90 120 86 120 87 122 86 117 78 116 83 
10 117 72 114 73 122 80 116 70 117 74 114 72 115 74 
11 103 69 104 64 104 65 102 68 103 58 102 65 102 65 
12 123 81 131 80 117 77 125 76 119 74 115 80 125 82 
13 127 79 121 77 133 84 116 79 126 77 120 78 117 76 
14 125 74 121 72 130 78 126 76 126 70 121 72 120 70 
15 120 70 111 64 114 74 117 73 114 70 112 66 111 65 
16 118 83 123 90 120 86 120 87 122 86 117 78 116 82 
17 117 72 115 72 122 80 116 70 117 74 114 72 115 73 
18 104 69 105 64 105 65 102 68 103 58 102 65 101 60 
19 122 81 131 80 117 77 124 76 118 73 114 80 125 82 
20 127 79 123 77 133 84 116 79 126 77 120 79 117 75 
21 124 81 133 80 119 77 126 76 120 74 124 83 125 82 
22 120 70 112 64 114 74 117 73 115 70 112 66 111 65 
23 121 70 111 64 114 74 117 73 114 69 113 66 112 64 
24 119 83 123 90 120 86 120 87 122 86 117 78 116 83 
25 117 72 114 72 120 80 117 70 118 74 115 70 114 74 
26 103 69 104 64 105 65 102 68 103 58 102 65 100 64 
27 123 81 131 80 117 77 124 76 118 73 114 80 125 89 
28 127 79 121 77 133 84 116 79 126 77 120 79 118 76 
29 125 80 133 80 119 77 126 76 120 73 124 83 124 82 
30 120 70 111 64 114 74 117 73 115 70 112 66 112 64 
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Group-II: 1:80000 
Table-4: Effect of lignocaine 2% with adrenaline 1:80000 on SPO2 
S.NO Before Administration Immediate  05 min 10 min 15 min 20 min 30 min 
1 98 98 98 98 98 99 98 
2 98 96 97 97 98 96 98 
3 98 98 96 98 97 98 98 
4 98 98 99 98 98 98 98 
5 98 93 98 98 97 98 98 
6 99 98 99 98 99 99 98 
7 98 98 98 98 98 98 98 
8 98 98 98 98 98 98 98 
9 98 98 98 98 98 98 98 
10 98 98 98 98 98 98 98 
11 99 99 99 98 99 99 98 
12 99 96 99 99 95 99 96 
13 98 98 98 98 98 98 98 
14 98 98 97 98 98 98 98 
15 98 98 98 98 98 98 98 
16 98 98 97 98 98 98 98 
17 99 98 99 99 99 99 98 
18 99 98 99 99 99 100 99 
19 98 97 97 98 98 98 98 
20 97 98 96 96 96 94 96 
21 97 98 98 94 98 98 96 
22 98 97 97 98 98 99 99 
23 98 98 97 98 99 98 96 
24 98 98 98 98 98 98 98 
25 99 98 98 99 99 99 98 
26 99 98 99 99 99 99 99 
27 98 98 97 98 98 98 98 
28 97 98 97 97 96 94 96 
29 98 98 98 97 98 98 96 
30 98 99 99 99 98 98 98 
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Table-5: Effect of lignocaine 2% with adrenaline 1:80000 on heart 
rate 
S.NO Before 
Administration 
Immediate 05 min 10 min 15 min 20 min 30 min 
1 57 60 67 58 61 69 58 
2 91 87 88 84 82 89 84 
3 69 58 64 76 73 75 74 
4 82 83 92 92 85 79 87 
5 81 84 80 82 96 78 82 
6 102 107 88 98 94 98 93 
7 79 81 82 83 84 79 80 
8 55 56 69 89 54 53 54 
9 86 75 70 88 85 84 83 
10 85 87 90 91 96 89 89 
11 92 97 88 98 94 98 98 
12 90 99 99 99 98 100 98 
13 96 78 70 98 85 94 93 
14 76 75 85 83 78 78 75 
15 85 87 90 90 96 89 89 
16 76 75 85 83 78 78 78 
17 80 89 89 89 90 98 97 
18 75 74 80 89 74 75 84 
19 51 55 54 51 56 55 52 
20 98 83 86 91 91 85 88 
21 95 95 88 88 70 90 84 
22 91 89 84 80 79 87 86 
23 69 62 69 73 70 71 74 
24 82 82 83 90 84 79 82 
25 79 89 92 84 89 78 81 
26 99 100 93 92 94 98 90 
27 80 84 80 79 83 79 82 
28 64 72 67 88 89 53 55 
29 68 79 72 83 82 84 82 
30 59 83 89 92 96 89 84 
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Table-6: Effect of lignocaine dilution 1:80000 on blood pressure 
S.No 
 
Before 
Administration Immediate 05 min 10 min 15 min 20 min 30 min 
SBP DBP SBP DBP SBP DBP SBP DBP SBP DBP SBP DBP SBP DBP 
1 131 84 122 81 127 80 119 71 121 81 118 73 110 72 
2 113 87 110 66 113 73 111 70 109 70 111 66 103 63 
3 114 74 107 69 122 71 112 67 116 62 117 69 118 79 
4 108 74 109 71 112 75 108 72 103 63 106 56 107 61 
5 125 89 122 87 119 78 122 84 111 78 121 80 115 74 
6 123 81 120 75 122 75 134 84 125 74 135 77 125 68 
7 121 74 118 84 119 76 113 74 109 63 113 73 115 67 
8 122 82 120 69 112 65 119 66 122 69 118 69 121 73 
9 120 75 121 78 121 80 120 67 122 71 119 69 123 69 
10 123 70 110 67 112 70 122 61 128 71 120 73 119 72 
11 124 81 121 75 122 78 130 75 125 74 131 77 128 68 
12 134 82 134 80 137 83 137 86 126 81 117 80 116 77 
13 120 75 122 78 133 80 117 67 120 71 118 69 123 69 
14 122 71 117 69 116 65 130 84 122 68 120 73 121 62 
15 123 70 108 66 111 70 122 61 123 71 120 73 119 69 
16 123 71 118 69 116 65 130 84 123 68 121 73 122 62 
17 135 82 132 80 139 83 138 86 126 81 117 80 116 77 
18 119 70 118 76 108 61 108 62 104 62 110 67 100 67 
19 151 71 154 77 163 81 178 76 169 77 154 78 145 72 
20 133 77 132 71 130 73 141 74 135 63 134 59 130 66 
21 130 80 120 80 125 82 118 70 121 81 118 73 110 72 
22 110 83 119 65 111 73 111 70 109 70 111 66 103 63 
23 100 77 110 68 121 71 112 68 118 65 117 69 118 79 
24 102 72 110 70 110 75 108 72 103 63 105 56 107 61 
25 120 85 120 86 118 77 122 84 111 78 121 79 115 74 
26 122 82 122 74 120 76 134 84 125 74 135 77 124 68 
27 128 70 119 82 110 75 113 74 109 63 113 73 115 67 
28 120 80 121 70 115 64 119 66 122 69 118 69 121 73 
29 122 76 120 77 128 82 120 67 122 71 119 69 123 70 
30 199 72 119 65 110 69 122 61 128 71 120 73 119 72 
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Group-III: 1:200000 
Table-7: Effect of Lignocaine 2% with adrenaline 1:200000 on SPO2 
Sl. 
No. 
Before 
Administration Immediate 
05 
min 
10 
min 
15 
min 
20 
min 
30 
min 
1 97 97 98 97 97 97 98 
2 98 96 96 98 97 97 96 
3 98 98 98 98 98 98 98 
4 99 100 99 99 86 99 98 
5 97 97 99 98 98 98 98 
6 98 97 98 98 98 98 98 
7 97 98 98 99 98 98 98 
8 98 98 98 98 98 98 98 
9 98 98 98 98 98 98 98 
10 98 98 98 98 98 98 98 
11 98 97 98 98 98 98 98 
12 98 99 98 98 98 98 98 
13 98 98 99 98 98 98 98 
14 97 98 98 98 97 98 98 
15 98 98 98 98 97 97 98 
16 97 98 98 98 97 98 98 
17 98 97 99 99 99 98 99 
18 99 95 99 99 96 99 100 
19 97 97 98 98 98 98 98 
20 97 96 98 98 98 97 98 
21 98 98 94 98 98 98 98 
22 98 97 98 98 98 98 98 
23 98 99 99 98 98 98 98 
24 98 98 99 98 98 98 98 
25 97 98 98 98 97 98 98 
26 98 98 98 97 97 97 98 
27 97 98 98 98 97 98 98 
28 98 97 99 98 99 98 99 
29 99 99 99 99 96 99 99 
30 97 97 98 98 97 98 98 
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Table-8: Effect of lignocaine 2% with adrenaline 1:200000 on heart 
rate 
S.NO Before 
Administration 
Immediate 05 
min 
10 
min 
15 
min 
20 
min 
30 
min 
1 67 71 70 62 63 68 69 
2 96 90 90 88 80 84 77 
3 64 63 76 76 70 82 72 
4 80 88 85 86 98 80 83 
5 87 81 79 79 78 81 84 
6 97 94 102 91 96 96 91 
7 87 81 79 79 78 81 86 
8 55 54 59 58 55 61 67 
9 91 94 89 85 86 84 84 
10 85 87 90 90 96 89 89 
11 97 95 98 91 96 96 91 
12 89 98 98 96 97 98 98 
13 101 104 99 95 86 94 94 
14 74 78 87 90 76 74 74 
15 77 75 80 78 77 72 80 
16 74 78 84 89 78 74 74 
17 81 86 84 80 81 85 84 
18 79 78 72 74 81 79 75 
19 50 55 55 51 50 51 51 
20 88 83 80 82 78 81 86 
21 67 71 72 62 63 68 69 
22 96 90 89 88 80 84 77 
23 64 63 76 76 74 82 72 
24 80 88 85 86 98 82 83 
25 87 81 79 79 78 81 84 
26 97 94 99 91 96 96 91 
27 87 81 79 79 78 81 86 
28 55 55 59 58 55 61 67 
29 91 93 89 84 86 84 84 
30 85 84 90 99 96 89 89 
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Table-9: Effect of lignocaine 2% with adrenaline 1:200000 on Blood 
Pressure 
S.No 
 
Before 
Administration Immediate 05 min 10 min 15 min 20 min 30 min 
SBP DBP SBP DBP SBP DBP SBP DBP SBP DBP SBP DBP SBP DBP 
1 119 75 113 67 118 75 118 74 116 67 115 72 115 68 
2 132 89 128 77 121 78 121 85 115 87 113 74 107 74 
3 114 69 103 61 112 66 129 72 113 65 121 71 124 68 
4 109 74 112 83 110 68 117 72 114 73 114 69 109 68 
5 137 86 124 82 118 75 113 71 123 99 117 69 116 84 
6 126 77 126 85 131 66 128 81 121 77 122 76 117 73 
7 139 86 126 82 120 75 115 71 123 79 119 69 118 84 
8 110 57 101 55 109 64 107 58 108 64 107 57 112 64 
9 130 88 144 74 129 85 134 85 124 80 122 87 119 72 
10 116 71 114 71 117 72 118 64 112 63 110 75 109 64 
11 127 77 124 85 131 66 129 81 122 77 128 76 117 73 
12 121 75 115 67 118 75 120 74 116 75 115 72 115 68 
13 130 88 124 73 131 85 137 85 124 82 122 87 119 74 
14 124 77 124 85 131 66 120 81 121 76 122 77 117 73 
15 116 71 115 71 117 72 115 64 112 63 108 65 110 75 
16 124 77 121 85 131 66 131 84 121 76 122 77 119 73 
17 122 75 116 74 119 75 121 74 117 75 116 72 116 74 
18 110 68 115 66 125 73 111 68 105 75 114 75 108 72 
19 150 73 159 80 168 91 153 73 139 66 143 76 140 71 
20 137 86 124 82 118 75 133 75 135 75 135 74 134 78 
21 119 77 113 67 118 75 118 74 116 67 115 72 114 66 
22 132 82 128 77 121 78 122 86 115 87 113 74 107 74 
23 115 69 103 61 112 66 129 72 113 65 121 71 124 68 
24 109 74 112 83 110 68 117 74 114 73 114 69 109 68 
25 136 86 124 82 118 75 115 71 123 99 117 69 116 84 
26 125 77 126 85 131 66 128 81 121 77 122 76 117 73 
27 139 86 126 82 120 75 115 72 123 79 118 70 116 84 
28 116 57 106 57 109 64 107 58 108 64 107 57 112 64 
29 130 88 144 74 119 85 124 85 126 79 124 87 119 72 
30 116 71 114 71 117 72 118 64 112 63 110 75 109 64 
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Table-10: Mean values of SPO2  in different groups 
Groups 
Before 
Administration 
Immediate 
05 
min 
10 
min 
15 
min 
20 
min 
30 
min 
Group-I 
(Lignocaine) 
95.73 
±6.51 
94.80 
±6.81 
95.17 
±7.24 
95.70 
±7.06 
95.73 
±6.73 
96.27 
±5.89 
94.67 
±7.19 
Group-II  
(1:80000) 
98.13 
±0.57 
97.70 
±1.09 
97.87 
±0.90 
97.93 
±0.94 
98.00 
±1.29 
97.70 
±0.91 
97.70 
±0.92 
Group-III 
(1:200000) 
97.77 
±0.63 
97.63 
±0.99 
98.10 
±0.99 
98.10 
±0.48 
97.23 
±2.24 
97.93 
±0.52 
98.10 
±0.61 
 
 
Table-11: Mean values of heart rate in different groups 
Groups Before 
Administration 
Immediate 05 min 10 min 15 min 20 min 30 min 
Group-I 
(Lignocaine) 
80.53 
±13.91 
77.27 
±15.28 
81.83 
±13.09 
79.30 
±12.76 
79.47 
±13.10 
83.10 
±13.90 
82.30 
±12.49 
Group-II 
(1:80000) 
79.73 
±13.60 
80.83 
±13.16 
81.10 
±10.65 
85.37 
±10.57 
82.87 
±11.90 
81.70 
±12.72 
81.20 
±12.32 
Group-III 
(1:200000) 
80.93 
±13.78 
81.10 
±13.12 
82.43 
±11.92 
80.73 
±12.10 
80.13 
±13.44 
80.60 
±11.04 
80.37 
±10.02 
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Table-12: Mean values of systolic blood pressure 
Groups 
Before 
Administration 
Immediate 
05 
min 
10 
min 
15 
min 
20 
min 
30 
min 
Group-I 
(Lignocaine) 
119.13 
±7.12 
118.80 
±9.43 
118.53 
±8.11 
117.33 
±7.13 
117.30 
±6.85 
114.53 
±6.21 
115.23 
±7.38 
Group-II 
(1:80000) 
124.57 
±17.22 
119.83 
±9.31 
120.73 
±11.47 
123.00 
±14.01 
120.23 
±12.37 
119.90 
±9.76 
117.70 
±9.03 
Group-III 
(1:200000) 
124.33 
±10.50 
120.80 
±12.52 
121.63 
±11.27 
122.10 
±9.70 
118.40 
±7.81 
118.20 
±7.80 
116.13 
±7.35 
 
 
Table-13: Mean values of diastolic blood pressure 
Groups 
Before  
Administration 
Immediate 
05 
min 
10 
min 
15 
min 
20 
min 
30 
min 
Group-I  
(Lignocaine) 
75.77 
±5.54 
74.30 
±8.96 
77.37 
±6.39 
75.40 
±5.76 
72.73 
±7.69 
73.67 
±6.64 
74.07 
±8.15 
Group-II 
 (1:80000) 
77.23 
±5.67 
74.17 
±6.47 
74.20 
±6.13 
72.90 
±8.16 
70.77 
±6.17 
71.27 
±6.39 
77.70 
±9.03 
Group-III  
(1:200000) 
76.87 
±8.51 
74.80 
±8.10 
73.07 
±6.95 
74.30 
±7.91 
74.90 
±9.59 
73.00 
±6.82 
72.23 
±5.96 
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STATISTICAL ANALYSIS OF THE RESULTS 
The statistical analysis was performed using SPSS software(statistical package 
for social sciences)version16.0. The data was interpreted at a confidence interval of 
95%. One way ANOVA applied for statistical significance between the groups. Post 
hoc test followed by sheff test was used  for multiple comparison to find statistical 
significance. P value < 0.05 was considered statistically significant. 
Table-14: Comparison of SPO2 values before administration with different time 
intervals within each groups  
No significant changes are seen within the groups at different time periods. 
Table -15: Multiple comparison of SPO2 values with different time intervals 
within each groups  
No significant changes are seen within the groups at different time periods. 
Table-16: Comparison of heart rate before administration and at different time 
intervals within each group. 
Statistical analysis in Group 1 shows minor variations in HR which was not 
significant.. Group II shows a significant increase in heart rate at 10 min. by 5 beats 
per min.  
Table -17: Multiple comparison of heart rate with different time intervals within 
each groups. 
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Group 1 shows minor variations in HR which was not significant.. Group II shows a 
significant increase in heart rate at 10 min. by 5 beats per min.  
Table-18: Comparison of systolic blood pressure before administration with 
different time intervals within each groups. 
Group II shows a significant decrease in SBP immediately after administration by 5 
mm Hg, at 20 min period by 5 mm Hg and at 30 min period by 7 mm Hg. Group III 
shows significant   decrease in heart rate at 15 min and 20 min by 6 mm Hg and at 30 
min by 7 mm Hg. 
Table -19: Multiple comparison of systolic blood pressure with different time 
intervals within each group. 
Group II shows a significant decrease in SBP immediately after administration by 5 
mm Hg, at 20 min period by 5 mm Hg and at 30 min period by 7 mm Hg. Group III 
shows significant   decrease in heart rate at 15 min and 20 min by 6 mm Hg and at 30 
min by 7 mm Hg. 
Table-20: Comparison of diastolic blood pressure before administration with 
different time intervals within each group. 
Group II shows significant decrease in DBP by 6 mmHg at 15 min period and by 6 
mmHg at 20 min period. Group III shows significant decrease in DBP by 5 mmHg at 
30 min period. 
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Table -21: Multiple comparison of diastolic blood pressure with different time 
intervals within each group. 
Group II shows significant decrease in DBP by 6 mmHg at 15 min period and by 6 
mmHg at 20 min period. Group III shows significant decrease in DBP by 5 mmHg at 
30 min period. 
Table-22: Comparison of mean values of SPO2 of Group-I with other groups at 
different 
No significant changes are seen between the groups at different time periods. 
Table-23: Multiple comparison of mean values of SPO2 of groups at different 
time period 
No significant changes are seen between the groups at different time periods. 
Table-24 Comparison of mean values of heart rate of Group-I with other groups 
at different time periods 
Shows significant increase in HR in Group II by 5 beats /min immediately after 
administration. 
Table-25: Multiple comparison of mean values of heart rate of  groups at 
different time periods 
Shows significant increase in HR in Group II by 5 beats / min immediately after 
administration. 
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Table-26: Comparison of mean values of systolic blood pressure of Group-I with 
other groups at different time periods 
Shows significant increase in SBP by 6 mmHg in group II at 10 min period and 5 mm 
Hg at 20 min . There is a significant increase in SBP by 3 mmHg in group III at 5 min 
period. 
Table-27: Multiple comparisons of mean values of systolic blood pressure of 
groups at different time periods. 
Shows significant increase in SBP by 6 mmHg in group II at 10 min period and 5 mm 
Hg at 20 min . There is a significant increase in SBP by 3 mmHg in group III at 5 min 
period 
Table-28: Comparison of mean values of diastolic blood pressure of Group-I 
with other groups at different time periods. 
No significant changes are seen between the groups at different time periods. 
Table-29: Multiple comparison of mean values of diastolic blood pressure of 
groups at different time periods 
No significant changes are seen between the groups at different time periods. 
Graph-1: Comparison of SPO2 values in Group-I (Lignocaine)  
Shows no significant changes in SPO2 
Graph-2: Comparison of SPO2 values in Group-II (1:80000 dilution)  
Shows no significant changes in SPO2 
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Graph-3: Comparison of SPO2 values in Group-III (1:200000 dilution)  
Shows no significant changes in SPO2 
Graph-4: Multiple comparison of SPO2 values with different time intervals 
within the groups  
Shows no significant changes in SPO2 
Graph-5: Comparison of heart rate in Group-I (Lignocaine) . 
Group 1 shows no significant changes ih HR. 
Graph-6: Comparison of heart rate in Group-II (1:80000 dilutions) . 
Group II shows a significant increase in heart rate at 10 min 
Graph-7: Comparison of heart rate in Group-III (1:200000 dilutions). 
Shows no significant changes in HR 
Graph-8: Multiple comparison of heart rate with different time intervals within 
the groups  
Group 1 shows significant decrease in heart rate at 10 min. Group II shows a 
significant increase in heart rate at 10 min. 
Graph-9: Comparison of systolic blood pressure in Group-I (Lignocaine 2%)  
Graph-10: Comparison of systolic blood pressure in Group-II (1:80000 dilutions)  
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Group II shows a significant decrease in SBP immediately after administration, at 
20min and 30min 
Graph-11: Comparison of systolic blood pressure in Group-III (1:200000 
dilutions)  
Group III shows significant   decrease in heart rate at 15 min, 20 min and at 30 min. 
Graph-12: Multiple comparison of systolic blood pressure with different time 
intervals within the groups  
Group II shows a significant decrease in SBP immediately after administration, at 
20min and 30min. Group III shows significant   decrease in heart rate at 15 min, 20 
min and at 30 min. 
Graph-13: Comparison of diastolic blood pressure in Group-I (Lignocaine 2%)  
Graph-14: Comparison of diastolic blood pressure in Group-II (1:80000 dilution)  
Group II shows significant decrease in DBP at 15 min period and at 20 min period. 
Graph-15: Comparison of diastolic blood pressure in Group-III (1:200000 
dilutions)  
Group III shows significant decrease in DBP by at 30 min period. 
Graph-16: Multiple comparison of diastolic blood pressure with different time 
intervals within each groups. 
Group II shows significant decrease in DBP at 15 min period and at 20 min period. 
Group III shows significant decrease in DBP by at 30 min period.  
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TABLES  
Table-14: Comparison of SPO2 values before administration with different time 
intervals within each group  
Groups 
Group-I  
(MEAN±SD) 
Group-II  
(MEAN±SD) 
Group-III 
(MEAN±SD) 
Before 
Administration 
95.73±6.51 98.13±0.57 97.77±0.63 
Immediate 94.80±6.81 97.70±1.09 97.63±0.99 
5 min 95.17±7.24 97.87±0.90 98.10±0.99 
10 min 95.70±7.06 97.93±0.94 98.10±0.48 
15 min 95.73±6.73 98.00±1.29 97.23±2.24 
20 min 96.27±5.89 97.70±0.91 97.93±0.52 
30 min 94.67±7.19 97.70±0.92 98.10±0.61 
 
Table -15: Multiple comparison of SPO2 values with different time intervals 
within each group  
Groups 
Group-I 
(MEAN±SD) 
Group-II  
(MEAN±SD) 
Group-III  
(MEAN±SD) 
Before  
Administration 
95.73±6.51 98.13±0.57 97.77±0.63 
Immediate 94.80±6.81 97.70±1.09 97.63±0.99 
5 min 95.17±7.24 97.87±0.90 98.10±0.99 
10 min 95.70±7.06 97.93±0.94 98.10±0.48 
15 min 95.73±6.73 98.00±1.29 97.23±2.24 
20 min 96.27±5.89 97.70±0.91 97.93±0.52 
30 min 94.67±7.19 97.70±0.92 98.10±0.61 
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Table-16: Comparison of heart rate before administration and at different time 
intervals within each group. 
Groups 
Group-I  
(MEAN±SD) 
Group-II 
(MEAN±SD) 
Group-III  
(MEAN±SD) 
Before 
Administration 
80.53±13.91 79.73±13.60 80.93±13.78 
Immediate 77.27±15.28 80.83±13.16 81.10±13.12 
5 min 81.83±13.09 81.10±10.65 82.43±11.92 
10 min 79.30±12.76 85.37±10.57* 80.73±12.10 
15 min 79.47±13.10 82.87±11.90 80.13±13.44 
20 min 83.10±13.90 81.70±12.72 80.60±11.04 
30 min 82.30±12.49 81.20±12.32 80.37±10.02 
(*P<0.05 significant compared heart rate before administration with 10 min) 
Table -17: Multiple comparison of heart rate with different time intervals within 
each group. 
Groups 
Group-I 
(MEAN±SD) 
Group-II 
(MEAN±SD) 
Group-III 
(MEAN±SD) 
Before 
administration 
80.53±13.19 79.73±13.60 80.93±13.78 
Immediate 77.27±15.28 80.83±13.16 81.10±13.12 
5 min 81.83±13.09 81.10±10.65 82.43±11.92 
10 min 70.39±12.76*,#,┼ 85.37±10.57* 80.73±12.10 
15 min 79.47±13.10$ 82.87±11.90 80.13±13.44 
20 min 83.10±13.90$ 81.70±12.72 80.60±11.04 
30 min 82.30±12.49$ 81.20±12.32 80.37±10.02 
(*P<0.05 significant compared hear rate before administration with other 
groups, #P<0.05 significant compared heart rate immediate with other groups, 
┼P<0.05 significant compared heart rate 5 min with other groups, $P<0.05 
significant compared heart rate 10 min with other groups) 
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Table-18: Comparison of systolic blood pressure before administration with 
different time intervals within each groups 
Groups Group-I (MEAN±SD) 
Group-II 
(MEAN±SD) 
Group-III 
(MEAN±SD) 
Before 
Administration 119.13±7.12 124.57±17.22 124.33±10.50 
Immediate 118.80±9.43 119.83±9.31* 120.80±12.52 
5 min 118.53±8.11 120.73±11.47 121.63±11.27 
10 min 117.33±7.13 123.00±14.01 122.10±9.70 
15 min 117.30±6.85 120.23±12.37 118.40±7.81* 
20 min 114.53±6.21 119.90±9.76* 118.20±7.80* 
30 min 115.23±7.38 117.70±9.03* 116.13±7.35* 
(*P<0.05 significant compared systolic blood pressure before administration with 
other groups) 
Table -19: Multiple comparison of systolic blood pressure with different time 
intervals within each groups 
Groups 
Group-I  
(MEAN±SD) 
Group-II  
(MEAN±SD) 
Group-III  
(MEAN±SD) 
Before 
Administration 
119.13±7.12 124.57±17.22 124.33±10.50 
Immediate 118.80±9.43 119.83±9.31* 120.80±12.52 
5 min 118.53±8.11 120.73±11.47 121.63±11.27 
10 min 117.33±7.13 123.00±14.01 122.10±9.70 
15 min 117.30±6.85 120.23±12.37 118.40±7.81* 
20 min 114.53±6.21 119.90±9.76*,# 118.20±7.80* 
30 min 115.23±7.38 117.70±9.03*,# 116.13±7.35* 
(*P<0.05 significant compared systolic blood pressure before administration with 
other groups, #P<0.05 significant compared systolic blood pressure 10 min with 
other groups) 
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Table-20: Comparison of diastolic blood pressure before administration with 
different time intervals within each groups 
Groups Group-I (MEAN±SD) 
Group-II 
(MEAN±SD) 
Group-III 
(MEAN±SD) 
Before 
Administration 
75.77±5.54 77.23±5.67 76.87±8.51 
Immediate 74.30±8.96 74.17±6.47 74.80±8.10 
5 min 77.37±6.39 74.20±6.13 73.07±6.95 
10 min 75.40±5.76 72.90±8.16 74.30±7.91 
15 min 72.73±7.69 70.77±6.17* 74.90±9.59 
20 min 73.67±6.64 71.27±6.39* 73.00±6.82 
30 min 74.07±8.15 77.70±9.03 72.23±5.96* 
(*P<0.05 significant compared diastolic blood pressure before administration 
with other groups) 
Table -21: Multiple comparison of diastolic blood pressure with different time 
intervals within each groups 
Groups Group-I 
(MEAN±SD) 
Group-II 
(MEAN±SD) 
Group-III 
(MEAN±SD) 
Before 
Administration 
75.77±5.54 77.23±5.67 76.87±8.51 
Immediate 74.30±8.96 74.17±6.47 74.80±8.10 
5 min 77.37±6.39 74.20±6.13 73.07±6.95 
10 min 75.40±5.76 72.90±8.16 74.30±7.91 
15 min 72.73±7.69 70.77±6.17* 74.90±9.59 
20 min 73.67±6.64 71.27±6.39* 73.00±6.82 
30 min 74.07±8.15 77.70±9.03 72.23±5.96* 
(*P<0.05 significant compared diastolic blood pressure before administration 
with other groups) 
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Table-22: Comparison of mean values of  SPO2 of Group-I with other groups at 
different time period  
Groups Before Administration Immediate 
05 
min 
10 
min 
15 
min 
20 
min 
30 
min 
Group-I 
(Lignocaine) 
95.73 
±6.51 
94.80 
±6.81 
95.17 
±7.24 
95.70 
±7.06 
95.73 
±6.73 
96.27 
±5.89 
94.67 
±7.19 
Group-II 
(1:80000) 
98.13 
±0.57 
97.70 
±1.09 
97.87 
±0.90 
97.93 
±0.94 
98.00 
±1.29 
97.70 
±0.91 
97.70 
±0.92 
Group-III  
(1:200000) 
97.77 
±0.63 
97.63 
±0.99 
98.10 
±0.99 
98.10 
±0.48 
97.23 
±2.24 
97.93 
±0.52 
98.10 
±0.61 
 
 
 
 
 
Table-23: Multiple comparison of mean values of SPO2  of groups at different 
time period 
Groups Before Administration Immediate 
05 
min 
10 
min 
15 
min 
20 
min 
30 
min 
Group-I 
(Lignocaine) 
95.73 
±6.51 
94.80 
±6.81 
95.17 
±7.24 
95.70 
±7.06 
95.73 
±6.73 
96.27 
±5.89 
94.67 
±7.19 
Group-II 
(1:80000) 
98.13 
±0.57 
97.70 
±1.09 
97.87 
±0.90 
97.93 
±0.94 
98.00 
±1.29 
97.70 
±0.91 
97.70 
±0.92 
Group-III 
(1:200000) 
97.77 
±0.63 
97.63 
±0.99 
98.10 
±0.99 
98.10 
±0.48 
97.23 
±2.24 
97.93 
±0.52 
98.10 
±0.61 
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Table-24 Comparison of mean values of heart rate of Group-I with other groups 
at different time periods 
(*P<0.05 significant compared heart rate at immediate between group-I and 
group-II) 
Table-25: Multiple comparison of mean values of heart rate of groups at 
different time periods 
(*P<0.05 significant compared heart rate at immediate between group-I and 
group-II) 
 
Groups Before 
Administration 
Immediate 05 
min 
10 
min 
15 
min 
20 
min 
30 
min 
Group-I 
(Lignocaine) 
80.53 
±13.91 
77.27 
±15.28 
81.83 
±13.09 
79.30 
±12.76 
79.47 
±13.10 
83.10 
±13.90 
82.30 
±12.49 
Group-II 
(1:80000) 
79.73 
±13.60 
81.83 
±13.16* 
81.10 
±10.65 
85.37 
±10.57 
82.87 
±11.90 
81.70 
±12.72 
81.20 
±12.32 
Group-III 
(1:200000) 
80.93 
±13.78 
80.10 
±13.12 
82.43 
±11.92 
80.73 
±12.10 
80.13 
±13.44 
80.60 
±11.04 
80.37 
±10.02 
Groups Before 
administration Immediate 5 min 
10 
min 
15 
min 
20 
min 
30 
min 
Group-I 
(Lignocaine) 
80.53 
±13.91 
77.27 
±15.28 
81.83 
±13.09 
79.30 
±12.76 
79.47 
±13.10 
83.10 
±13.90 
82.30 
±12.49 
Group-II 
(1:80000) 
79.73 
±13.60 
81.83 
±13.16* 
81.10 
±10.65 
85.37 
±10.57 
82.87 
±11.90 
81.70 
±12.72 
81.20 
±12.32 
Group-III 
(1:200000) 
80.93 
±13.78 
80.10 
±13.12 
82.43 
±11.92 
80.73 
±12.10 
80.13 
±13.44 
80.60 
±11.04 
80.37 
±10.02 
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Table-26: Comparison of mean values of systolic blood pressure of Group-I with 
other groups at different time periods 
Groups Before Administration Immediate 05 min 10 min 
15 
min 
20 
min 
30 
min 
Group-I 
(Lignocaine) 
119.13 
±7.12 
118.80 
±9.43 
118.53 
±8.11 
117.33 
±7.13 
117.30 
±6.85 
114.53 
±6.21 
115.23 
±7.38 
Group-II  
(1:80000) 
124.57 
±17.22 
119.83 
±9.31 
120.73 
±11.47 
123.00 
±14.01* 
120.23 
±12.37 
119.90 
±9.76* 
117.70 
±9.03 
Group-III 
(1:200000) 
124.33 
±10.50 
120.80 
±12.52 
121.63 
±11.27* 
122.10 
±9.70* 
118.40 
±7.81 
118.20 
±7.80 
116.13 
±7.35 
(*P<0.05 significant compared systolic blood pressure group-I with other 
groups) 
 
 
 
Table-27: Multiple comparison of mean values of systolic blood pressure of 
groups at different time periods 
Groups Before 
Administration 
Immediate 05 min 10 min 15 
min 
20min 30 
min 
Group-I 
(Lignocaine) 
119.13 
±7.12 
118.80 
±9.43 
118.53 
±8.11 
117.33 
±7.13 
117.30 
±6.85 
114.53 
±6.21 
115.23 
±7.38 
Group-II 
(1:80000) 
124.57 
±17.22 
119.83 
±9.31 
120.73 
±11.47 
123.00 
±14.01* 
120.23 
±12.37 
119.90 
±9.76* 
117.70 
±9.03 
Group-III  
(1:200000) 
124.33 
±10.50 
120.80 
±12.52 
121.63 
±11.27* 
122.10 
±9.70* 
118.40 
±7.81 
118.20 
±7.80 
116.13 
±7.35 
(*P<0.05 significant compared systolic blood pressure group-I with other 
groups) 
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Table-28: Comparison of mean values of diastolic blood pressure of Group-I 
with other groups at different time periods 
 
 
 
Table-29: Multiple comparison of mean values of diastolic blood pressure of 
groups at different time periods 
 
 
Groups Before 
Administration 
Immediate 05 
min 
10 
min 
15 
min 
20 
min 
30 
min 
Group-I 
(Lignocaine) 
75.77 
±5.54 
74.30 
±8.96 
77.37 
±6.39 
75.40 
±5.76 
72.73 
±7.69 
73.67 
±6.64 
74.07 
±8.15 
Group-II 
(1:80000) 
77.23 
±5.67 
74.17 
±6.47 
74.20 
±6.13 
72.90 
±8.16 
70.77 
±6.17 
71.27 
±6.39 
77.70 
±9.03 
Group-III 
(1:200000) 
76.87 
±8.51 
74.80 
±8.10 
73.07 
±6.95 
74.30 
±7.91 
74.90 
±9.59 
73.00 
±6.82 
72.23 
±5.96 
Groups 
Before 
Administration 
Immediate 
05 
min 
10 
min 
15 
min 
20 
min 
30 
min 
Group-I 
(Lignocaine) 
75.77 
±5.54 
74.30 
±8.96 
77.37 
±6.39 
75.40 
±5.76 
72.73 
±7.69 
73.67 
±6.64 
74.07 
±8.15 
Group-II 
(1:80000) 
77.23 
±5.67 
74.17 
±6.47 
74.20 
±6.13 
72.90 
±8.16 
70.77 
±6.17 
71.27 
±6.39 
77.70 
±9.03 
Group-III 
(1:200000) 
76.87 
±8.51 
74.80 
±8.10 
73.07 
±6.95 
74.30 
±7.91 
74.90 
±9.59 
73.00 
±6.82 
72.23 
±5.96 
  
 
Graph-1: Comparison of SPO
 
 
Graph-2: Comparison of SPO
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Graph-3: Comparison of SPO
 
Graph-4: Multiple comparison of SPO
within the groups  
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Graph-5: Comparison of heart rate in Group
 
 
Graph-6: Comparison of heart rate in Group
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Graph-7: Comparison of heart rate in
 
Graph-8: Multiple comparison of heart rate with different time intervals within 
the groups  
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Graph-9: Comparison of systolic blood pressure in Group
 
Graph-10: Comparison of systolic blood pressure in Group
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Graph-11: Comparison of systolic blood pressure in Group
dilution)  
Graph-12: Multiple comparison of systolic blood pressure with different time 
intervals within the groups 
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Graph-13: Comparison of diastolic blood pressure in Group
 
 
Graph-14: Comparison of diastolic blood pressure in Group
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Graph-15: Comparison of diastolic blood pressure in Group
dilution)  
 
Graph-16: Multiple comparison of diastolic blood pressure with different time 
intervals within the groups 
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Graph-17 : Multiple comparison of mean values of  SPO
time period 
Graph-18: Multiple comparison of mean values of  heart rate of  groups at 
different time periods 
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Graph-19: Multiple comparison of mean values of systolic blood pressure of 
groups at different time periods
 
Graph-20: Multiple comparison of mean values 
groups at different time periods
108
110
112
114
116
118
120
122
124
B
lo
o
d 
 
Pr
e
ss
u
r
e
66
68
70
72
74
76
78
Bl
o
o
d 
Pr
es
su
re
 
of diastolic blood pressure of 
 
TIME
Group-I Group-II Group-III
TIME
Group-I Group-II Group-III
Results 
61 
 
 
Interpretation Results 
 
 62 
 
Statistical analysis within the group shows no significant changes in oxygen 
saturation in group I, group II and group III in any of the recorded time periods. 
Group I showed only minor variations in HR which was not significant.  
Group II presented with a gradual increase in HR after LA administration with its  
peak  increase at 10min of study period by 5 beats/min. Then it gradually decreased at 
15 min and 20 min., reaching the pre administration levels at 30min.  A mild increase 
in HR was noticed in group III by 5 min after administration, but was not significant. 
The increase in HR was significant in Group II compared with Group I and Group III. 
The SBP in group I was seen to decrease after administration of LA, but was 
not statistically significant. In group II a decrease in SBP was noticed immediately 
after administration compared to pre administration values with a mean decrease of 
5mmHg, and was then found to increase gradually at 5min and 10min. After 10min, 
SBP again decreased at 15min, 20min and 30min. time periods with a mean decrease 
of 7mm Hg from pre administration levels. Group III elicited a decrease in SBP 
showing a maximum decrease at 30 min with a mean of 6 mmHg. The fall in SBP was 
more in group II on comparing with group III, but was not significant. 
  Group I showed only minor changes in DBP without any statistical 
significance.  In Group II there was a decrease in DBP after administration of LA with 
a maximum decrease seen at 15 min by 6 mmHg from pre administration levels. It 
then gradually increased over 20min and reaching the pre administration levels at 
30min. Group III showed a gradual decrease in DBP with a maximum decrease seen 
at 30 min, with mean decrease being 5 mmHg. 
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Lignocaine with adrenaline combination is the most widely used local 
anaesthetic agent in dental practice46. The addition of adrenaline to local anaesthesia 
becomes essential in minor surgical procedures as adrenaline counteracts the known 
vasodilator activity of  lignocaine by causing  vasoconstriction and  there by acting as 
a chemical tourniquet. This improves the depth and duration of anaesthesia and also 
reduces the systemic anaesthetic toxicity52.  
However these vasoconstrictors have been reported to influence blood 
pressure and heart rate1,20. Epinephrine stimulates adrenergic receptors which are 
responsible for their vasoconstrictor and other properties. There are two basic 
categories of adrenergic receptors, alpha adrenergic receptors and beta adrenergic 
receptors.  Alpha adrenergic effects leads to peripheral vasoconstriction and beta 
adrenergic agonism causes increased rate and force of contraction of the heart and 
vasodilatation in muscles23. Thus epinephrine increases the systolic pressure and heart 
rate and decreases diastolic pressure. This property of epinephrine raises the 
controversy regarding the use of epinephrine in local anaesthetics in patients with 
cardiovascular disease. Though such effects of local anaesthesia with different 
epinephrine concentrations have been investigated, it is not well established. This 
study was designed to compare hemodynamic changes upon administration of local 
anaesthetic agents with their different concentrations of adrenaline through a period 
thirty minutes in otherwise healthy individuals. 
Meechan et al23 reported that cardiac transplant patients experienced a 
significant tachycardia 10 min after intra oral injection of the epinephrine-containing 
local anaesthetic solution with out any change in the systolic and diastolic blood 
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pressure. In the present study a similar increase in heart rate was noticed at 10 min 
period in lignocaine with adrenaline 1:80,000 concentration. 
Another study by Meral et al32  comparing the effects of lignocaine with or 
without adrenaline on hemodynamic changes during third molar surgery   showed  
clinically negligible increase in HR and BP and oxygen saturation after injection of 
LA with epinephrine. Meechan and Rawlins in 1987 also found no significant 
changes in HR or SBP associated with the injection of 50 micrograms of adrenaline53. 
In 1988 they demonstrated a reduction in diastolic blood pressure following 
administration of adrenaline containing local anaesthetics54. The present study we 
found out no changes in oxygen saturation and a reduction in DBP at 15 min by 
6mmHg from pre administration levels in lignocaine with adrenaline 1:80,000 
concentration. 
Chaudhry et al47 observed a decrease of 21mm Hg in systolic blood pressure 
in hypertensive patients while administered with 3.6 ml of a 2% lignocaine with 
1:100,000 epinephrine. A fall in DBP as well as HR was also noticed in this study. 
Gedik31 and Takahashi et al55 also noticed a decrease in SBP and HR during 
administration of local anaesthetic containing adrenaline in healthy patients. They 
observed a 4-5mmHg decrease in SBP after five minutes in a group that received 
10micrograms of epinephrine in 2% lignocaine with a final volume of 4ml. We found 
a 7 mm Hg decrease in SBP after administration of 1.8 ml of lignocaine with 
adrenaline 1:80,000 concentration and 6 mm Hg decrease in SBP for lignocaine with 
adrenaline 1:2,00,000 in healthy individuals. 
The decrease in BP may be attributed to very small plasma concentration of 
epinephrine in dental local anaesthesia 30. The amount of epinephrine in two 
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cartridges of dental local anaesthetic injection is 45 micrograms. This concentration is 
reported to have predominant effect on cardiac ß-2 receptors and little effect on alpha 
receptors. When this is combined with lignocaine, which itself is a vasodilator, results 
in decrease in BP in otherwise healthy patients30.  
In  another  study conducted to record changes in hemodynamic parameters 
during functional endoscopic sinus surgery (FESS) after local infiltration with and 
without epinephrine showed a significant fall in blood pressure after  injection of 
lignocaine with epinephrine (1:200,000) as compared to other groups that received a 
normal saline injection which was used as a placebo35. Hanuman et al28 reported 
hemodynamic changes after scalp surgery using different concentrations of lignocaine 
and epinephrine. They concluded that lignocaine alone does not produce any 
significant change in hemodynamic parameters. This is in accordance with the present 
study which revealed insignificant haemodynamic changes associated with plain 
lignocaine. 
Niwa et al24 reported a 4.1% increase in SBP and 5.1% increase in HR 
immediately after injection of lignocaine with adrenaline. No change in diastolic 
blood pressure was noted. Knoll-Kohler et al56 also demonstrated a slight increase in 
HR after injection of low dose epinephrine.  
Clintron et al57 reported that dental anaesthesia with 1.0ml of 2% lignocaine 
with 1:1,00,000 epinephrine caused no significant change in HR or blood pressure and 
was well tolerated by patients with recent myocardial infarction. Davenport58 also 
reported insignificant hemodynamic changes with moderate doses of epinephrine used 
during periodontal surgery. 
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The amount of epinephrine absorbed following local dental anaesthesia has 
been hypothesized to be less than the amount produced endogenously in response to 
pain due to inadequate anaesthesia or due to anxiety associated with the procedure59. 
Studies investigating the administration of 1.8 ml of 2% lidocaine with 
epinephrine1:100,000 (18µg) reported elevated plasma epinephrine levels with 
minimal cardiovascular changes11.  Troullos et al demonstrated elevated circulating 
levels of epinephrine following administration of 8 dental cartridges of lignocaine 
with adrenaline 1:1,00,000 and associated elevations in systolic pressure,heart rate, 
and myocardial oxygen consumption12.The plasma epinephrine threshold for increase 
in heart rate is reported to be 50- 100 pg/ml60. The threshold level for increases in 
systolic blood pressure is 75 - 125 pg/ml, while 150 -200 pg/ml results in decreases in 
diastolic blood pressure 60. 
Bader et al29 reported that local anaesthesia with epinephrine used in 
hypertensive patients is associated with increase in SBP for 4 mmHg and no higher 
for normotensive subjects. HR was higher in patients receiving epinephrine than that 
with plain lignocaine group and DBP was found to decrease for both normotensive 
and hypertensive individuals. These changes were similar to the haemodynamic 
changes noted in the present study. 
In this study, oxygen saturation did not show any significant changes before 
and after administration of local anaesthesia. This was in accordance with the results 
obtained by Meral32 ,Vasconcellos38 and Liau37. 
Considering hemodynamic study parameters, heart rate seen in  group I(plain 
lignocaine) showed only minor variations which was not significant.In group II, there 
was an increase in the HR with its  peak  at 10min by 5 beats/min. Group III also 
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showed an  increase in the heart rate but was not statistically significant. The rise in 
HR was in accordance with the studies by Niwa et al24  and Knoll-Kohler 56.  
The present study also showed that the pre administration SBP was higher 
than the values recorded at any other time periods. A decrease in systolic blood 
pressure was noted after administration in all the three groups compared to the pre 
administration levels. Group I elicited only a mild decrease in SBP. In group II there 
was a  decrease noted immediately after administration with a mean decrease of 
5mmHg followed by an elevation in SBP with its peak at 10 min period. It was again 
found to decrease at 15 min. 20 min and 30 min periods with a mean decrease of 
7mmHg from pre administration levels. In Group III a  decrease in SBP was noted at 
30 min  with a mean of 6 mmHg. Chaudhry et al47 and Takahashi et al55 also noticed 
similar haemodynamic changes while using local anaesthetics with adrenaline. 
In this study, a decrease in the diastolic blood pressure was noted at 15 min 
and 20 min by 6 mmHg and then gradually increases, reaching the pre administration 
levels at 30 min. in group II. Group III showed a gradual decrease in DBP with a 
maximum decrease seen at 30 min, with mean decrease being 5 mmHg. Meechan54 
and Gedik31 also demonstrated a reduction in diastolic blood pressure following 
administration of adrenaline containing local anaesthetics. 
According to Hagigath33 the increase in HR and SBP before administration 
can be attributed to needle phobia and stress during pre administration period .Once 
the needle is withdrawn, there is disappearance of fear and stress leading to a decrease 
in HR and SBP immediately after injection.  
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Dionne et al12 reported that intraoral injections can cause endogenous 
epinephrine release which along with exogenously administered epinephrine causing 
a rise in HR and SBP during post injection period. 
Pallasch et al61 reported that epinephrine usually increases HR, SBP, 
myocardial oxygen consumption and cardiac automaticity but reduces DBP. This 
explains for the reduction in DBP in group II and group III following local 
anaesthesia administration in the present study. 
In this study we found minor variations in HR, SBP and DBP with adrenaline 
concentrations of 1:80,000 and 1:2,00,000 dilutions when compared to plain 
lignocaine. All these variations were found to be more in lignocaine with 
adrenaline1:80,000 group (GroupII), even though it was not prominent. 
Summary & Conclusion 
 
 69 
 
The present study was conducted on a local population of sample size thirty 
evaluating their haemodynamic changes using pulse oxymetry while administering 
lignocaine alone and lignocaine with adrenaline in different concentration of 1:80,000 
and 1: 2,00,000 in otherwise healthy individuals. It was noticed that oxygen saturation 
did not show any variations while using lignocaine with different concentrations of 
adrenaline. Those patients who received plain  lignocaine 2% showed only minor 
variations in heart rate which was not significant after administration while  patients 
who received lignocaine  with adrenaline showed an increase in heart rate which was 
more in 1:80,000 group compared to 1:2,00,000 group. The decrease  in systolic 
blood pressure was also found to be more in 1:80,000 group than 1:2,00,000 group. 
Diastolic blood pressure did not show any variations in those patients who received 
plain lignocaine  but was noted to be decreasing in patients receiving local anaesthesia 
with adrenaline in concentration of 1:80,000. Adrenaline in 1:2,00,000 concentration 
also showed a decrease in diastolic blood pressure , but  was not as low as that of  
adrenaline  1:80,000. 
This analysis showed variation in heart rate, systolic blood pressure and 
diastolic blood pressure in patients who received lignocaine with adrenaline 
concentrations of 1:80,000 and 1:2,00,000. These variations were more in adrenaline 
concentrations of 1:80,000 than 1:2,00,000, but was not marked. 
To conclude, even though use of lignocaine with adrenaline is associated with  
changes in blood pressure and heart rate, clinically they are less significant and such 
changes did not produce any marked systemic untoward outcome at any of the studied 
adrenaline concentrations of 1:80,000 or 1:2,00,000. 
 
Bibliography 
 
 X 
 
1. Hitoshi Niwa, Yasuaki Hirota, Tohru Sibutani, Yoshiko Idohji, Tomonori Hori, 
Kazuna Sugiyama, Shigeharu Joh, Akiyoshi Kuji, Hideo Matsuura. The effects of 
epinephrine and norepinephrine administered during local anaesthesia on left 
ventricular diastolic function. Anesth Prog1991;Vol 38:221-226. 
2. Maria Angeles Serrrera Figallo, Rocio T. Velazquez Cayon, Daniel Torres 
Lagares, Jose Ramon Corcuera Flores, Guillermo Machuca Portillo. Use of 
anaesthetics associated to vasoconstrictors for dentistry in patients with 
cardiopathies. Review of the literature published in the last decade. J Clin Exp 
Dent 2012;Vol 4(2):107-111 
3. Joseph M. Neal. Effects of epinephrine in local anaesthetics on the central and 
peripheral nervous systems: Neurotoxicity and neural blood flow. Regional 
Anaesthesia and Pain Medicine 2003;Vol 28(2):124-134 
4. Gerardo Gomez-Moreno, Javier Guardia, Antonio Cutando, Jose Luis Calvo-
Guirado. Pharmacological interactions of vasoconstrictors. Med Oral Patol Oral 
Cir Bucal.2009;Vol14(1):E20-27 
5. Fadia Bou Dagher, Ghassan M. Yared, Pierre Machtou. An evaluation of 2% 
lignocaine with different concentrations of epinephrine for inferior alveolar nerve 
block. J Endodon 1997;Vol23(3):178-180 
6. Fatima Neves Faraco, Paschoal Laercio Armonia, Jose Leonardo Simone, Nicolau 
Tortamano. Assessment of cardiovascular parameters during dental procedures 
under the effect of benzodiazepines: A double blind study. Braz Dent J 
2003;Vol14(3):215-219 
Bibliography 
 
 XI 
 
7. Charles A. Venale. Cardiovascular responses to local dental anaesthesia with 
epinephrine in normotensive and hypertensive subjects. The journal of the 
American Dental Society of Anesthesiology 1962:132-138. 
8. Mary Stannard, Graeme Sloman, Linnet Sangster. Hemodynamic effects of 
lignocaine in acute myocardial infarction. Brit.med. J 1968; Vol2:468-469 
9. K.N. Christensen, J.K. Jensen, I. Sogaard. Blood pressure responses to 
administration of local anaesthetics with Noradrenaline in Craniotomies. Acta 
Neurochirurgica 1980;Vol51:157-160. 
10. David S. Goldstein, Raymond Dionne, James Sweet, Richard Gracely, Bryan 
Brewer, Richard Gregg, Harry R. Keiser. Circulatory, Plasma catecholamine, 
Cortisol, lipid, and psychological responses to a real –life stress (Third molar 
extractions): effects of Diazepam sedation and of inclusion of epinephrine with 
the local anaesthetic. Psychosomatic Medicine 1982; Vol44(3):259-272 
11. Chernow B, Balestrieri F, Ferguson CD, Terezhalmy GT, Fletcher JR, Lake CR: 
Local dental anaesthesia with epinephrine. Arch Intem Med 143:2141-2143, 1983. 
12. Emanuel S. Troullos, David S. Goldstein, Kenneth M. Hargreaves,  Raymond A. 
Dionne. Plasma Epinephrine Levels and Cardiovascular Response to High 
Administered Doses of Epinephrine in Local Anaesthesia. Anesth Prog. 1986 ; 
34(1): 10–13. 
13. Meyer F-U. Hemodynamics changes of local dental anaesthesia  in normotensive 
and hypertensive subjects. Int j Clin Pharm Thera Tox 1986; Vol24:477-481 
Bibliography 
 
 XII 
 
14. Abraham-Inpijin L, Borgneijer-Hoelen A, Gortzak RAT. Changes in blood 
pressure, heart rate and electrocardiogram during dental treatment with use of 
local anaesthesia. J Am Dent Assoc 1988; Vol116:531-536. 
15. Salonen M, Forssell h, Scheinin M. Local dental anaesthesia with lignocaine and 
adrenaline. Effects on plasma catecholamines, heart rate and blood pressure. Int J 
Oral Mxillofac Surg 1998; Vol17(6):392-394 
16. John G. Meechan, R. Richard Welbury. Metabolic responses to oral surgery under 
local anaesthesia and sedation with intravenous midazolam: The effects of two 
different local anaesthetics. Anesth Prog 1992; Vol39:9-12 
17. Renald Perusse, Jean-Paul Goulet, Jean-Yves Turcotte, Ste-Foy,Quebec. 
Contraindications to vasoconstrictors in dentistry: Part II. Oral Surr Oral Med Oral 
Pathol 1992; Vol74:687-691 
18. R.J. Middlehurst, A. Gibbs, G. Walton. Cardiovascular Risk:The safety of local 
anaesthesia, vasoconstrictors, and sedation in heart disease. Anesth Prog 1999; 
Vol46:118-123. 
19. Y. Homma, T. Ichinohe, Y. Kaneko. Oral mucosal  blood flow, plasma 
epinephrine and hemodynamic response after injection of lignocaine with 
epinephrine during midazolam sedation and isoflurane anaesthesia. Br J Anaesth 
1999; Vol82:570-574 
20. John A. Yagiela. Local anesthtics. Anesth Prog 1991;Vol38:128-141. 
 
Bibliography 
 
 XIII 
 
21. Hitoshi Niwa, Yuu Satosh, Hideo Matsuura, Osaka. Cardiovascular responses to 
epinephrine-containing local anesthetics for dental use: A comparison of 
hemodynamic responses to infiltration anaesthesia ergometer-stress testing. Oral 
surg Oral Med Oral Pathol Oral Radiol Endod 2000; Vol90:171-181. 
22. Makoto Tanaka, Toru Goyagi, Tetsu Kimura, Toshiaki Nishikawa. The efficacy of 
hemodynamic and T wave criteria for detecting intravascular injection of 
epinephrine test doses in anesthetized adults: A dose-response study. Anesth 
Analg 2000; Vol91:1196-1202. 
23. J.G. Meechan, B. Cole, R.R. Welbury. The influence of two different dental local 
anesthetic solutions on the hemodynamic responses of children undergoing 
restorative dentistry:a randomised,single –blind,split-mouth study. British Dental 
Journal 2001; Vol190(9):502-504 
24. Hitoshi Niwa, Mitsutaka Sugimura, Yuu Satoh, Ai Tanimoto. Cardiovascular 
response to epinephrine-containing local anaesthesia in patients with 
cardiovascular disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 
Vol92:610-616 
25. Elie M. Fernieini, Jeffrey D. Bennett, David G. Silverman, Thomas M. 
Halaszynski, Farmington, New Haven, Conn. Hemodynamic assessment of local 
anesthetic administration by Laser Doppler flowmetry .Oral Surg Oral Med Oral 
Pathol Oral Radiol Endod 2001; Vol91:526-530. 
26. Hitoshi Niwa, Mitsutaka Sugimura, Yuu Satoh, Ai Tanimoto. Cardiovascular 
response to epinephrine-containing local anaesthesia in patients with 
cardiovascular disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 
Vol92:610-616 
Bibliography 
 
 XIV 
 
27. Shinobu Ohkado, Tatsuya Ichinohe, Yuzuru Kaneko. Comparitive study on 
anesthetic potency depending on concentrations of lignocaine and epinephrine: 
Assessment of dental local anesthetics using the jaw-opening reflex. Anesth Prog 
2001; Vol48:16-20. 
28. Hanuman S. Murthy, G. S. Umamaheswara Rao. Cardiovascular responses to 
scalp infiltration with different concentrations of epinephrine with or without 
lignocaine during craniotomy. Anesth Analg 2001; Vol92:1516-1519. 
29. James D. Bader, Arthur j. Bonito, Daniel A. Shugars,Chapel Hill. A systemic 
review of cardiovascular effects of epinephrine on hypertensive dental patients. 
Oral Surg Oral Med Oral Pathol Oral Pathol Oral Radiol Endod 2002; Vol93:647-
653 
30. Yang JJ, Wang TY, Wang J. Marked hypotension  induced by adrenaline 
contained in local anesthetic. Laryngoscope.2003; Vol115(2):348-352. 
31. RG Gedik, I Marakoglu, S Demirer. Blood pressure, heart rate and temperature 
variability during periodontal surgery. West Indian Med J 2005; Vol54(5):329-
333. 
32. Gokee Meral, Ferda Tasar, Filiz Sayin, Mustafa Saysel, Sedef Kir, Erdem 
Karabulut, Ankara. Effects of lignocaine with or without epinephrine on plasma 
epinephrine and lignocaine concentrations and hemodynamic values during third 
molar surgery. Oral Surg Oral Med Oral Pathol oral Radiol Endod 2005; 
Vol100:E25-30. 
Bibliography 
 
 XV 
 
33. A. Haghighat, N. Kaviani, R. Panahi. Hemodynamic effects of 2% lignocaine with 
1:80000 Epinephrine in inferior alveolar nerve block. Dental research Journal 
2006; Vol3(1):4-7 
34. Hitoshi Niwa, Ai Tanimoto, Mitsutaka Sugimura, Yoshinari Morimoto, Hiroshi 
Hanamoto, Osaka, Kyoto. Cardiovascular effects of epinephrine under sedation 
with nitrous oxide, propofol, or midazolam. Oral Surg Oral Med Oral Pathol Oral 
Radiol Endod 2006; Vol 102:E1-E9 
35. Yang JJ, Wang TY, Wang J. Marked hypotension induced by adrenaline 
contained in local anaesthetic. Laryngoscope.2006; Vol115(2):348-352. 
36. Fatima N. Faraco, Paulo Y. Kawakami, Maria J. Mestnik, Daniel S. Ferrari, Jamil 
A. Shibli. Effects of anaesthetics containing lignocaine and epinephrine on 
cardiovascular changes during dental implant surgery. Journal of Oral 
Implantology 2007; Vol(2):84-88. 
37. Fanny Liliani Liau, Sang-Heng Kok, Jang-Jaer Lee,Ru-Cheng Kuo, Chia-Rong 
Hwang, Puo-Jen Yang, Chung-Ping Lin, Ying-Shiung Kuo, Hao-Hueng Chang. 
Cardiovascular influence of dental anxiety during local anaesthesia for tooth 
extraction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; Vol105:16-
26. 
38. Ricardo Jose de Holanda Vasconcellos, Belmiro Cavalcanti do Egito Vasconcelos, 
Paloma Rodrigues Genu. Influence of local anaesthetics with adrenaline 
1:100.000 in basic vital constants during third molar surgery. Med Oral Patol Oral 
Cir Bucal 2008; Vol13(7):E31-37. 
Bibliography 
 
 XVI 
 
39. Ali Moshaver, Denny Lin, Ruxandra Pinto, Witterick. The haemostatic and 
hemodynamic effects of epinephrine during endoscopic sinus surgery. Arch 
Otolaryngol Head Neck Surg.2009; Vol135(10):1005-1009 
40. Alessendra Batistela Laragnoit, Ricardo Simoes Neves, Itamara Lucia Itagiba 
Neves, Joaquim Edson Vieira. Locoregional anaesthesia for dental treatment in 
cardiac patients: A comparative study of 2% plain lignocaine and 2% lignocaine 
with epinephrine(1:100,000). CLINICS 2009; Vol 64(3):177-182. 
41. Marcelo Carlos Bortoluzzi, Rafael Manfro, Anderson Nardi. Glucose levels and 
hemodynamic changes in patients submitted to routine dental treatment with and 
without local anaesthesia. Clinics 2010;Vol65(10):975-978. 
42. Mohammad Abbas Tariq, Mohammad Kamran, Mumtaz Ali. Cardiovascular 
responses to scalp infiltration using adrenaline, with or without lignocaine, during 
craniotomy. JPMI 2010; Vol24(2):142-146. 
43. Tatjana Goranovic, Irena Pirkl, Goran Gudelj, Boris Zdilar, Branimir Vuckovic, 
Boris Simunjak, Kata Sakic. The effect of injection speed on hemodynamic  
changes immediate after lignocaine/adrenaline infiltration of nasal submucosa 
ander general anaesthesia. Periodicum Biologorum 2011; vol113(2):217-221 
44. Drazen Vnuk, Visnja Nesek-Adam, Marko Pecin, Andrija Musulin, Niksa Lemo, 
Natasa Brajenovic,Irena Brcic Karaconji, Berislav Radisic, Ozren Smolec, Marija 
Lipar. Hemodynamic effects of epidural lignocaine vs lignocaine-adrenaline in 
dogs. Vet.archiv2011; Vol81(5):585-589 
45. Francisco-Javier Silvestre, Isabel Salvador-Martinez, Daniel Bautista, Javier 
Silvestre-Rangil. Clinical study of hemodynamic changes during extraction in 
controlled hypertensive patients. Med Oral Patol Oral Cir Bucal 
2011;Vol16(3):e354-358. 
Bibliography 
 
 XVII 
 
46. MO Ogunlewe, O James, J NA Ajuluchukwu AL Ladeinde, WL Adeyemo, OM 
Gbotolrun. Evaluation of hemodynamic changes in hypertensive patients during 
tooth extraction under local anaesthesia. West Indian Med J 2011; Vol60(1):91-95 
47. Saima Chaudhry, Hafiz Aamer Iqbal, Faisal Izhar, Kamran Masood Mizra, Nabiha 
Farasat Khan, Raheela Yasmeen, Ayyaz Ali Khan. Effect on blood pressure and 
pulse rate after administration of an epinephrine containing dental local 
anaesthetic in hypertensive patients. J Pak Med Assoc 2011; Vol61:1088-1091 
48. Shivaraj Sivanmalai, Sivakumar Annamalai, Snthosh Kumar, Christon Naveen 
Prince, Chandrakala, Vinod Thangaswamy. Pharmacodynamics responses of 
exogenous epinephrine during mandibular third molar surgery. Journal of 
Pharmacy and Bioallied Sciences 2012; Vol4;S390-S393 
49. Mohammad Ketabi, Mehrnaz Sadighi Shamami, Maryam Alaie, Mehrnoosh 
Sadighi Shamami. Influence of local anaesthetics with or without epinephrine 
1/80000 on blood pressure and heart rate: A randomized double-blind 
experimental clinical trial. Dental Research Journal 2012; Vol9:437-440. 
50. Daniel Torres-Lagares, Maria-Angeles Serrera-Figallo, Guillermo machuca-
Portillo, Jose-Ramon Corcuera-Flores, Carmen Machuca-Portillo,Raquel Castillo-
Oyague, Jose-Luis Gutierrez-Perez. Cardiovascular effect of dental anaesthesia 
with articaine(40 mg with epinephrine 0.5 mg % and 40 mg with epinephrine 1 
mg %) versus mepivacaine(30 mg and 20 mg with epinephrine 1 mg %) in 
medically compromised cardiac patients: a cross-over, randomized, single blinded 
study. Med Oral Patol Oral Cir Bucal 2012; Vol17(4):e655-660. 
Bibliography 
 
 XVIII 
 
51. Seyed Ali Mohammad Miratashi, Shekoufeh Behdad, Vida Ayatollahi, Afsar 
Ahmadi. Hemodynamic effects of intraocular epinephrine during cataract surgery: 
a double blinded placebo controlled randomized clinical trial. Nepal J Opthalmol 
2012; Vol4(8):288-294. 
52. Maria Angeles Serrrera Figallo, Rocio T. Velazquez Cayon, Daniel Torres 
Lagares, Jose Ramon Corcuera Flores, Guillermo Machuca Portillo. Use of 
anaesthetics associated to vasoconstrictors for dentistry in patients with 
cardiopathies. Review of the literature published in the last decade. J Clin Exp 
Dent 2012;Vol 4(2):107-111. 
53. Meechan J G, Rawlins MD. The effects of adrenaline in lignocaine anaesthetic 
solutions on plasma potassium in healthy volunteers. Eur. J Clin Pharmacol 
1987;32:81-4. 
54. Meechan J G, Rawlins MD . The effects of two different local anaesthetic 
solutions on plasma potassium levels during third molar surgery. J Am Dent 
Assoc. 1988.;302:150-4. 
55. Takahashi Y, Nakano M, Sano K, Kanri T. The effects of epinephrine in local 
anesthetics on plasma catecholamine and hemodynamic responses. Odontology 
2005; 93: 72-9. 
56. Knoll- Kohler E, Frie A, Becker J, Ohlendrof D. Changes in plasma epinephrine 
concentration after dental infiltration anaesthesia with different doses of 
epinephrine. J Dent Res, 1989;68: 1098-1101. 
Bibliography 
 
 XIX 
 
57. Cintron G, Medina R, Reyes A , Lyman G. Cardiovascular effects and safety of 
dental anaesthesia and dental interventions in patients with recent uncomplicated 
myocardial infarction. Arch Intern Med 1986;146;2203-4. 
58. Davenport RE, Porcelli RJ, Iacono VJ, Bonura CF, Mallis GI, Baer PN. Effects of 
anaesthetics containing epinephrine on catecholamine levels during periodontal 
surgery. J Periodontol. 1990;61:553-8. 
59. Fiset L, Ramsey D, Milgrom P, Weinsein P: The effects of lignocaine with 
epitephrine on fear related arousal among dental phobics. Anesth Progr 33:225-
229, 1986. 
60. Clutter WE, Bier DM, Shah SD, Cryer PE: Epinephrine plasma metabolic 
clearance rates and physiologic thresholds for metabolic and hemodynamic 
actions in man. J Clin Invest 66:94-101, 1980. 
61. Pallasch T. Vasoconstrictors and the heart. J Calif Dent Assoc. 1998;26:668-
73,676. 
